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Due to the rapid rise of noncommunicable diseases (NCDs), the Uganda Ministry of 
Health (MoH) has prioritized NCD prevention, early diagnosis, and management. In partnership 
with the World Diabetic Foundation, MoH has embarked on a countrywide program to build 
capacity of the health facilities to address NCDs. A needs assessment was developed and 
conducted in 13 regional referral hospitals, 27 general hospitals, and 14 health center IVs in 
Uganda to: (1) assess the capacity of health units to detect and manage noncommunicable 
diseases; (2) describe provider knowledge, attitudes, resources, and practices, and (3) identify 
areas of improvement and areas in need of funding and training. Quantitative data on the human 
resources and skills, NCDs prevalence, services, equipment, medicines and stockouts, laboratory 
tests, referral system, health care providers’ skills and attitudes, community engagement, and 
NCD association membership were collected through the needs assessment, and qualitative 
interviews were conducted for supplemental information. Data were analyzed and summary 
statistics (N, % and Mean ±SD, where applicable) for each facility type were generated, and 
frequencies and percents were used to summarize each of the major aspects of the health 
facilities. Results of this assessment demonstrate that there remain significant gaps in the 
resources and personnel at all facilities. Although there is variability among them, none of the 
facilities meet the WHO standards for essential tools and medicines to implement effective 
NCDs interventions. The regional referral hospitals fare the best compared to general hospitals 
and health center IVs, but all facilities report a concerning lack of NCD screening and care 
services. The assessment results demonstrate the need for Uganda to scale-up low cost, high 
impact NCD interventions and strengthen the knowledge and capacity of health personnel to 
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This needs assessment analysis has three (3) objectives: 
1. To assess the capacity of health units to detect and manage noncommunicable diseases 
2. To describe provider knowledge, attitudes, resources, and practices 
3. To identify areas of improvement and areas in need of funding and training 
 
This report is for the partial fulfillment of the requirements for the degree of Masters of Public 
Health at the Yale School of Public Health. It is also being sent to the Uganda Ministry of Health 
Program for the Prevention and Control of Noncommunicable Diseases for future use in building 




A. Geography and demographics 
 
Uganda is a landlocked country in East Africa, north of Lake Victoria. Its total area is 
241,038 km2, with 19,100 km2 of land and 43,938 km2 of water. Uganda’s estimated population 
is 36,346,000, and the population growth rate is 3.32%.1 This is the second highest growth rate in 
the world, and Uganda’s population is projected to be over 130 million in 2050.2 The urban 
population is 15.6% of the total population. The population proportion under 15 years old is 
48.54%, while 3.72% of the population is over 60 years old.3,4 The capital city of Uganda is 
Kampala, which has a population of 1,723,300 million people. The sex ratio of the total 
population is 95 males per 100 females. The gross national income per capita is $1,120, and 





The Ugandan government is decentralized, and functions of the local government are 
specified for district level and sub-county level. According to the Local Government Act of 
1997, the reason for decentralization was to address the necessity to administer effectively, bring 
the services closer to the people, and “account for the means of communication, geographical 
features, population density, and economic viability.” There are currently 132 districts, 162 
counties, and 1,116 sub-counties.6 
 
C. Health system 
 
The National Health System of Uganda consists of both public and private sectors. The 
public sector includes all health facilities under the Ministry of Health (MoH), health services of 
the Ministries of Defense, Internal Affairs, and Ministry of Local Government. The private 
sector includes private health providers, private not for profit providers, and traditional medicine 
practitioners. The Ministry of Health (MoH) supervises the local governments’ delivery of health 
services and builds capacity within the local governments to enable them to meet the service 
delivery standards.7 
 
D. Health facility types 
 
Within the public sector, Uganda’s health facilities are separated into four categories: 1) 
National Referral Hospitals (NRHs), 2) Regional Referral Hospitals (RRHs), 3) General 
Hospitals, and 4) the Health Subdistrict System. The subdistrict system is split into Health Center 
Is, IIs, IIIs, and IVs. NRHs and RRHs provide comprehensive specialist services and have 
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research, education, and supervisory programs, in addition to offering services offered by the 
more general hospitals. Mulago NRH in Kampala, the capital city, is the only NRH in the 
country. RRHs also offer specialist services such as psychiatry, ear, nose, and throat, 
ophthalmology, more advanced surgical and medical services, and support services such as 
laboratory, medical imaging, and pathology. There are 13 RRHs, each serving a population of 
about 2,307,692. General hospitals provide preventive, curative, maternity, in-patient services, 
surgery, blood transfusion, laboratory, and medical imaging services. They also offer training 
and research for the community-based health care programs. They provide care for 500,000 
people. There are 164 health center IVs (HCIVs), which provide preventive, curative, and 
emergency surgery services. The HCIV population ratio is 1:187,500.7 
 
E. Health service delivery 
 
The Ugandan government owns most of the health facilities in the country. It owns 2242 
health centers and 59 hospitals. In comparison, private not for profit providers own 613 health 
facilities and 46 hospitals, and private health providers own 268 health centers and 8 hospitals.  
In 2001, Uganda abolished user fees. All public health facilities have free curative, 
preventive, rehabilitative, and promotive health services. Utilization of the health system is poor, 
even though 72% of households in Uganda are within 5 km from a health facility. MoH outlines 
the reasons for utilization as: poor infrastructure, lack of medicines and other supplies, shortage 
of human resources in the public sector, low salaries, lack of accommodation at health facilities, 
as well as other limiting factors. 
The minimum package of services is the Uganda National Minimum Health Care 
Package (UNMHCP). This package has four main parts, namely: (1) health promotion, disease 
 9 
prevention and community health initiatives; (2) maternal and child health; (3) prevention and 
control of communicable diseases; and (4) prevention and control of noncommunicable 
diseases.7 
 
F. Health profile 
 
The total life expectancy at birth is 50.2 years. Gender specific life expectancies are 48.8 
years for men and 52 years for women. The total fertility rate is 6.2 children per women, and the 
maternal mortality rate is 310 per 1000 live births.8,9 The infant mortality rate is 54 deaths per 
1000 live births, and the under five mortality rate is 90 deaths per 1000 live births. A quarter of 
Uganda’s people live below the national poverty line, and 73% of the population is literate.1 
Almost 90% of the population has access to improved sanitation.3 
The contraceptive prevalence in Uganda is 30%, and 48% of women have adequate 
antenatal care (4+ visits). Fifty eight percent (58%) of births are attended by skilled health 
personnel.10 Among girls aged 15-19%, 31.3% have an unmet need for family planning.3 The 
measles immunization rate for 1-year olds is 75%. There are 1.2 physicians for every 100,000 
people in Uganda, and there are 13.1 nurses and midwives per 100,000 population.10  
 In 2010, HIV/AIDS  (17.3%), malaria (14.2%), and lower respiratory infections (6.4%) 
were the highest ranking causes of years of life lost (YLLs) due to premature death.11 The 
current prevalence of HIV among adults 15-49 years old is 7.2%, and in 2011, there were 181 
deaths due to HIV/AIDS per 100,000 population.3 The top five leading causes of years lived with 
disability (YLDs) for all ages are iron-deficiency anemia, major depressive disorder, low back 
pain, HIV/AIDS, and malaria.11 
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 The three factors that account for the most disease burden are alcohol use, household air 
pollution from solid fuels, and childhood underweight.  In 2010, the top risk factor for adults 
aged 15-49 years was alcohol use, while that for children under 5 was childhood underweight.12  
 
G. Noncommunicable diseases: Burden 
 
The World Health Organization (WHO) classifies noncommunicable diseases (NCDs) as 
chronic non-infectious diseases.12 Noncommunicable diseases are the leading causes in the world 
of death and disability.13 Cardiovascular disease, cancer, respiratory disease, and diabetes are the 
most common noncommunicable diseases in the world.12 NCDs lead to huge economic burdens 
on individuals, families, and the healthcare system. The World Economic Forum considers 
NCDs to be one of the top threats to global economic development.14 Low- and middle-income 
countries account for 80% of noncommunicable disease-related deaths worldwide.12 The WHO 
has predicted that Africa in particular will have the greatest regional increase in NCD-related 
death over the next decade.15 
NCDs currently account for 25% of deaths in Uganda.16 The WHO estimates that 
cardiovascular disease accounts for 11% of deaths, cancers 4%, respiratory diseases 3%, diabetes 
1%, and other NCDs 6%. In 2008, the age-standardized death rate for all NCDs was 1094.7 
deaths per 100,000 in males and 684.9 deaths per 100,000 in females.16 In addition to the 
common NCDs such as hypertension, diabetes, cancer, and chronic respiratory diseases, the 
Ugandan MoH also considers mental illnesses, injuries, and oral diseases to be NCDs.7 Mental 
health contributes to 13% of the total disease burden,7 and injuries currently account for 10% of 
all deaths in Uganda.16 In Kampala, 25% of all deaths are due to injury, in particular road traffic 
crashes (46%) and assaults (16%).17 Other common injuries include falls, drowning, and burns.18 
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Two of the most common NCDs in Uganda are diabetes and hypertension. The overall 
prevalence of diabetes is relatively low, estimated at 2.9%,19 though there are regions with 
considerably higher prevalence. For example, the prevalence of type 2 diabetes in the districts of 
Kampala and Mukono is 8.1%. Of this population, nearly 80% of women are overweight and an 
association among overweight, hypertension, and diabetes in women is observed.20 In addition, 
rates of detection are low. There are now 560,000 registered patients in Uganda with diabetes, 
but it is predicted that an additional 560,000 people are unaware they have the chronic disease.21 
The prevalence of hypertension in the southwest regions of the country ranges from 20-30%.22, 23  
The WHO STEPwise approach to Surveillance (STEPS) of risk factors is a standardized 
method for WHO member countries to collect, analyze, and share data for chronic disease risk 
factors.24 A WHO-STEPS survey recently conducted in Kasese, a rural district in western 
Uganda, showed the prevalence of hypertension to be 22%, diabetes 9%, as well as high levels of 
risk factors, such as physical inactivity, overweight, and heavy tobacco smoking (51%, 15.6%, 
and 9.6%, respectively).25 
 
H. Noncommunicable diseases: Current efforts 
 
There has been a recent movement in Uganda to prioritize NCDs in government, 
academic research, and healthcare system. In 2006, the Ministry of Health (MoH) established a 
Program for the Prevention and Control of Noncommunicable Diseases. The program’s mandate 
is to reduce the morbidity and mortality attributable to NCDs through appropriate health 
interventions targeting the entire population.26 A planned baseline survey on risk factors and the 
magnitude of NCDs has not been conducted yet because of lack of funding. Uganda does not 
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currently have comprehensive data on NCDs, and there is no NCD policy, strategic plan, or 
standards and guidelines for managing NCDs.7   
In 2008, MoH partnered with the World Diabetes Foundation (WDF) to develop and 
implement a national diabetes and NCD program (WDF05-222). The project was set to run from 
2008-2012, but did not due to technical challengers. However, it became operational in 2013 and 
is expected to run until 2017. The program includes the “development of a policy, standards, 
guidelines, and an integrated, comprehensive work plan for the prevention, detection, and control 
of diabetes and related noncommunicable diseases.” This phase of the partnership includes 4 
main components: 1) policy, guidelines, and standards; 2) capacity building for improved 
diagnosis and care; 3) awareness in all population groups, including the nomadic and internally 
displaced persons; and 4) establishing and strengthening inter-sectoral collaborations with local 
and international stakeholders.27  
 
I. Rationale for needs assessment 
 
The second component of the MoH-WDF partnership, capacity building for improved 
diagnosis and care, is critical to improve the currently inadequate resources and skills of health 
workers in regards to NCDs. In 2013, WDF provided funding for a needs assessment to be 
conducted in various health units that cover primary, secondary, and tertiary care.27  
Prior to the development of this needs assessment, there was no regional or national tool 








A. Development of the needs assessment tool 
 
Background research was conducted to find the format and questions of needs 
assessments that were conducted in similar settings. The resources used include a past qualitative 
nationwide survey on the regional referral hospitals,28 a NCDs needs assessment used in 
Tanzania and Zanzibar, an International Diabetes Federation needs assessment used in the Africa 
region, and a NCDs needs assessment conducted by USAID in Albania, Armenia, Georgia, and 
Russia.29 
Priority NCDs were chosen by their mortality and morbidity in Uganda. These NCDs 
include diabetes, cancer, cardiovascular disease, renal disease, sickle cell disease, and chronic 
obstructive pulmonary disease.  
The World Health Organization’s Package for Essential Noncommunicable (PEN) 
Disease Interventions for Primary Health Care in Low-Resource Settings was used to determine 
the medicines, technologies, and tools on which to assess the health facilities (Appendix C).30 
PEN’s list of essential technologies and tools and list of core medicines for implementing 
essential NCD interventions in primary care were reviewed, and those that were available, or 
supposed to be available, in Uganda were included in the needs assessment. Additional 
medicines, technologies, tools, and guidelines deemed essential by MoH were also included. 
Hilary Rogers wrote the draft needs assessment tool with supervision from the Ministry 
of Health NCDs Programme. The final version of the tool was developed after a 1-day review 
with various Ugandan NCD experts and RRH managers. Thereafter, data collection with the 
needs assessment tool began in health facilities.  
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B. Sample of health facilities 
 
Three types of health facilities were included in this study: Regional Referral Hospitals, 
General Hospitals, and Health Center IVs. All 13 of the regional referral hospitals were assessed. 
Three to four facilities, general hospitals and/or health center IVs, were assessed in each of the 
RRH’s catchment area, resulting in 40 facilities in addition to the RRHs. Overall, 53 health units 
were assessed (Appendix A). 
 
C. Sample of health personnel 
 
Health personnel individually assessed during the MoH visit to determine their level of 
confidence in and attitudes towards managing NCDs. Different cadres and levels of health 
personnel were surveyed. These included nursing assistants, lab technicians, nurses and 
midwives, nursing officers, clinical officers, medical officers, physicians, and a hospital director. 
The selection process was based on convenience and availability of staff. (Table 15) 
 
D. Implementation of needs assessment 
 
Survey: 
The health units were assessed throughout July-November 2013 by MoH staff. Two to 
three staff members visited the facilities and conducted the needs assessment in the specific 
offices, clinics, pharmacy, laboratory, and wards. Aided by the heads of the health facilities and 






In addition to the quantitative data collection, interviews were conducted with health 
facility personnel when time allowed during several of the MoH visits to health facilities. These 
interviews were not formalized due to time and staff constraints, and no randomized selection of 
personnel was used. Eight health personnel were personally interviewed by Hilary Rogers after 
they filled out the individual confidence and attitudes section of the needs assessment. 
Interviewees were asked supplemental questions about confidence, attitudes, and gaps in training 
and knowledge. Interviews were recorded and then transcribed in the U.S. 
 
E. Data analysis 
 
After completing the needs assessment exercise, MoH compiled the data in a Microsoft 
Access database. These data were then cleaned and imported into Microsoft Excel and SAS for 
further analysis.  Data were analyzed and organized according to the organization of the original 
questionnaire (Appendix B).  Summary statistics (N, % and Mean ±SD, where applicable) for 
each facility type (regional referral hospital, general hospital, health center IV) were generated. 
Similarly, frequencies and percents were used to summarize each of the major categories of 
personnel, services, equipment, pharmaceutical drugs, laboratory services, health care providers’ 
skills and attitudes, referral system, community engagement and NCD association activities. For 
the providers’ skills and attitudes, the associations between type of health care cadre and each of 
the confidence levels and attitudes were examined using the χ2 test for trend with a significance 
level of 0.05. 
 16 
The personal interviews were not analyzed. The interviews were evaluated for common 
themes, and relevant segments of the interviews are included in the results section of this paper 
to supplement the quantitative data from the needs assessment. 
 
IV. Assessment findings 
 
A. Description of sample 
 
Thirteen (13) regional referral hospitals, 27 district (general) hospitals, and 14 health 
center IVs were assessed. Most of the regional referral hospitals were in urban areas (61.5%), 
while the majority of general hospitals and health center IVs were in rural areas (59.3% and 
64.3%, respectively). Given these are government-owned health facilities, it is assumed that the 
majority of facilities surveyed receive public support rather than private support (only 45% of 
each facility type answered this question). While none of the other two types of facility had a 
private facility, one (3.7%) of the general hospitals was described as private. (Table 1) 
 
B. Human resources  
 
In terms of general personnel, all regional referral hospitals had at least one clinical 
officer (100.0%), with an average of 10.6 (± 3.9) clinical officers at each hospital. Most had at 
least one medical officer (76.9%), with an average 5.3 (± 4.3) per hospital. The regional referral 
hospitals had very few specialist physicians. The majority of hospitals had at least one specialist 
physician (53.8%), general surgeon (69.2%), obstetrician/gynecologist (61.5%), pediatrician 
(53.8%), and physiotherapist (61.5%), but the average number of these staff members ranged 
from 1-3 per hospital. Out of all of the regional referral hospitals, there was one cardiologist, one 
 17 
endocrinologist/diabetologist, one pathologist, one psychiatrist, and one vascular surgeon. None 
of the regional referral hospitals had a neurologist, oncologist, or pulmonologist. 
Most of the regional referral hospitals reported having nurses (76.9%), with an average of 
47.8 (± 22.2) nurses at each hospital. Only 4 (30.8%) regional referral hospitals had at least one 
diabetic nurse, but 9 (69.2%) had a psychiatric nurse.  
The majority of the regional referral hospitals had laboratory technicians (84.6%), 
laboratory technologists (84.6%), and radiology technicians (69.2%), with an average of about 2 
staff members of each type per hospital. 
The regional referral hospitals lacked other types of health personnel that specialize in 
NCDs. Specifically, none of the hospitals had a NCDs counselor, and 7.7% had a foot care 
specialist and a NCD educator. 
As for general hospitals, the majority had medical (81.5%) and clinical officers (88.9%). 
Although a few had at least one general surgeon (11.1%) and OB/GYN (14.8%), the general 
hospitals did not have many specialist physicians.  
The 25.9% of general hospitals that had at least one diabetic nurse had an average of 1.4 
(±0.8) per facility. A larger number of hospitals (74.1%) had psychiatric nurses, with an average 
of 1.5 (±0.7) per facility. While seven of the general hospitals (25.9%) had a nutritionist, very 
few of them had a NCD counselor (3.7%) or NCD educator (3.7%), and none of them had a foot 
care specialist.  
As expected, the majority of the personnel in the health center IVs were medical and 
clinical officers and nurses. Only two health center IVs (14.3%) had at least one nurse trained in 
diabetes care. None of the health center IVs had a staff member trained in NCD counseling, 
NCD education, foot care, or nutrition. (Table 2) 
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C. Facility-based NCDs prevalence 
 
A patient was considered a “NCD patient” if their primary reason for visiting the health 
facility was a NCD. Due to the low rates of NCD screening in the facilities, it is unlikely that a 
patient would come in for another health issue and then be treated for a NCD. Although the 
breakdown of inpatient/outpatient is unknown, NCD patients are more likely to be in an 
outpatient setting. Only six regional referral hospitals were able to report the number of NCD 
patients in the facilities (Jinja, Kabale, Lira, Masaka, Mbale, and Mbarara). Many of the general 
hospitals and health center IVs also lacked data on the number of NCD patients.  Of the average 
number of overall patients in regional referral hospitals (118,513), 17.28% were NCD patients. 
On average, 6.18% of the patients in general hospitals and 1.79% of the patients in health center 
IVs had at least one NCD. Overall, NCD recording and reporting in the health facilities was 
noted to be very poor or inadequate. Therefore, these data on NCD prevalence, while 
informative, are not reliable. 
In the regional referral hospitals, injuries due to trauma not related to gender-based 
violence (2.18%), mental health disorders (1.53%), and diabetes for all ages (1.51%) had the 
highest average number of cases per year per overall patients in the facilities. Injuries due to 
trauma not related to gender-based violence (12.59%), mental health disorders (8.84%), diabetes 
for all ages (8.73%), adult diabetes (8.18%), hypertension (6.81%), and asthma (4.20%) had the 
highest average number of cases per patients with NCDs in the facilities. (Table 3) 
Table 4 describes the recorded cases of regional referral hospitals in detail. In Arua, the 
NCDs with the highest percentage of cases per number of overall patients were injuries due to 
trauma not related to gender-based violence (1.01%) and hypertension (1.00%). Gulu did not 
have records of specific NCDs cases, with the exception of 700 diabetes cases. In Hoima, mental 
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health disorders (3.89%) and total diabetes (0.83%) had the highest proportions within the 
number of overall patients. In Jinja, 68.30% of patients have an NCD. The most prevalent NCDs 
were mental health disorder (8.83%), injury due to trauma not related to gender-based violence 
(8.48%), and heart disease (4.43%). In Kabale, 11.66% of patients have an NCD, and mental 
health disorder (1.64%) and injury due to trauma not related to gender-based violence (1.48%) 
are the most prevalent. In Lira, 11.32% of patients have an NCD, and injury due to trauma not 
related to gender-based violence (33.01%), total diabetes (11.32%), and asthma (4.72%) are the 
most prevalent. The prevalence of NCDs in Masaka Regional Referral Hospital is 14.50%, with 
total diabetes (3.88%), adult diabetes (3.88%), and injury due to trauma not related to gender-
based violence (2.08) in the highest proportions. Mbale has a 27.74% NCDs prevalence among 
its patients, with asthma (4.12%), total diabetes (2.08%), adult diabetes (1.91%), and cancer 
(1.31%) in the highest proportions. Mbarara has a 14.51% NCDs prevalence among its patients, 
and total diabetes (3.91%), adult diabetes (3.90%), injury due to trauma not related to gender-
based violence (2.08%), and mental health disorder (2.00%) have the highest proportions of the 
overall number of patients. In Mityana, adult diabetes (1.42%) and injury from a road traffic 
accident (1.18%) have the highest prevalence. In Moroto, the NCDs with the most number of 
cases are injury from trauma due to other causes (1.73%) and hypertension (0.28%). In 
Mubende, total diabetes (2.44%) and hypertension (2.06%) have the highest prevalence. In 
Soroti, injury from trauma due to other causes (4.43%), asthma (0.58%), and injury from a road 
traffic accident (0.51%) have the highest prevalence. (Table 4) 
In the general hospitals, adult diabetes (2.94%), and injuries due to trauma not related to 
gender-based violence (1.94%) had the highest average number of cases per overall patients in 
the facilities. Adult diabetes (47.52%), injuries due to trauma not related to gender-based 
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violence (31.39%), childhood diabetes (10.75%), and hypertension (10.01%) had the highest 
average number of cases per patients with NCDs in the facilities. Chronic obstructive pulmonary 
disease was surprisingly high (68.31%), but this statistic is believed to be due to a reporting 
error, and is not accurate. 
In the health center IVs, chronic obstructive pulmonary disease (7.10%), injuries due to 
trauma not related to gender-based violence (0.45%), and hypertension (0.32%) had the highest 
average number of cases per overall patients in the facilities. The mean number of cases of 
chronic obstructive pulmonary disease was 5156 per health center IV, which is more than the 
mean number of NCDs patients (N=1300), which suggests another reporting error. Injuries due 
to trauma not related to gender-based violence (24.92%), hypertension (17.77%), asthma 
(14.46%), total diabetes (11.00%), and adult diabetes (10.69%) had the highest average number 
of cases per patients with NCDs in the facilities. (Table 3) 
 
D. Facility-based HIV prevalence 
 
NCDs and HIV infection often coincide. They both are most frequent in low- and middle-
income countries, with age-adjusted death rates nearly twice as high compared to high-income 
countries. HIV is also associated with high rates of NCDs. For example, a study in Kenya 
showed that HIV positive people had significantly higher rates of hypertension than those who 
were HIV negative. Due to the rapid expansion of HIV programs, people with HIV are living 
longer and aging, and thus developing other chronic conditions. There are also some 
opportunistic illnesses that are directly linked to HIV infection, such as HIV-associated 
lymphoma and cervical cancer.31  
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The care of HIV and NCDs also share many similarities. Both require the strengthening 
of primary health care, ongoing appointments, adherence to medications, healthy living, and self-
management.31 Furthermore, many scholars suggest leveraging effective HIV program 
approaches and service delivery models to address NCDs in resource-limited settings.32 The 
topic of integrating HIV and NCDs care and learning from the lessons of HIV services also came 
up in the interviews with health personnel. One staff member said, “It used to be you treat 
diabetes, you don’t think of…other conditions. But now, when you are treating for diabetes, you 
have to check for HIV.” Another staff member discussed how the strategy of “having focal 
people” who are trained to screen, treat, and refer HIV patients would also work for NCDs. 
Due to the overlap of HIV and NCDs, the needs assessment also examined the prevalence 
of HIV and comorbidities of HIV and NCDs in the health facilities. Only 3 regional referral 
hospitals, 4 general hospitals, and 4 health center IVs were able to sufficiently fill out the HIV 
prevalence section of the assessment. In each of the health facility types, there were more women 
with HIV in the last year than men. Specifically, 71.4% of the 5600 HIV patients were female in 
Jinja Regional Referral Hospital, 67.7% of the 753 HIV patients in Bududa General Hospital and 
60.6% of the 2431 in Serere Health Center IV were female. (Table 5) 
 
E. Clinics and services 
 
The majority of regional referral hospitals had a clinic specifically for diabetes (84.6%). 
Additionally, many had a clinic for hypertension (53.9%), OB/GYN (53.9%), HIV (53.9%), and 
medical outpatient (53.9%). Less than half of the regional referral hospitals had a clinic for 
surgery (38.5%), pediatrics (30.8%), sickle cell (30.8%), cancer (15.4%), cardiology (15.4%), 
renal disease (15.4%), and COPD (7.7%).  
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The majority of general hospitals had a clinic for medical outpatient (92.6%), HIV 
(63.0%), and diabetes (55.6%). Less than half had a clinic for OB/GYN (44.4%) or pediatrics 
(29.6%). Few of the general hospitals had a clinic for hypertension (18.5%), surgery (11.1%), 
sickle cell (7.4%), cancer (3.7%), or cardiology (3.7%). None of the general hospitals had a 
clinic for COPD or renal disease.  
In general, specialty clinics are not expected in health center IVs. None of the health 
center IVs had a clinic for cancer, cardiology, COPD, renal disease, sickle cell, pediatrics, or 
sickle cell. Most of them had a medical outpatient clinic (64.3%), and some had a clinic for HIV 
(28.6%), diabetes (21.4%), and OB/GYN (21.4%). One of the health center IVs had a 
hypertension clinic (7.1%). (Table 6) 
The majority of the regional referral hospitals that have NCDs clinics had separate clinic 
rooms and conduct regular patient review. However, very few of these hospitals perform clinic 
performance audits. WHO recommends audit tools for implementing essential NCD 
interventions (Appendix C). Half or less than half of the diabetes, hypertension, OB/GYN, 
pediatrics, HIV, surgery, and MOPD wards conduct clinic performance audits. These audits were 
not conducted in any of the cancer, cardiology, COPD, renal, or sickle cell clinics. (Table 7) 
The availability of NCD services such as body measurements, screening, laboratory tests, 
and advice and support, were assessed in the health facilities. Most of the health facilities 
conduct weight and height measurements. However, only 35.7% of health center IVs measure 
height. Very few of the regional referral hospitals and general hospitals measure BMI and 
waist:hip ratio, and health center IVs do not measure either.   
 Most of the health facilities measure blood pressure. All of the regional referral hospitals 
offer screen for high blood pressure, while 88.9% of general hospitals and 85.7% of health center 
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IVs do. The health facilities had low rates of screening for particular NCDs. Less than half of 
regional referral hospitals (30.8%) and health center IVs (42.9%) screen for sickle cell. While 
more than half of all facilities offer pap smears for cervical cancer screening, only 40.7% of 
general hospitals and health center IVs screen for breast cancer. Less than a quarter of regional 
referral hospitals (15.4%) offer prostrate cancer screening, and only 1 general hospital (3.7%) 
offers the screening. Less than half of all health facilities perform eye examinations. Similarly, 
only 61.5% of regional referral hospitals, 44.4% of general hospitals, and 21.4% of health center 
IVs record a patient’s family history of NCDs. 
 Most of the health facilities offer tests for oral glucose tolerance, blood lipids, urinalysis, 
urine proteins, and urine ketones. While none of the general hospitals or health center IVs offer 
cytology/pathology services, 30.8% of regional referral hospitals do.  
 About half of the regional referral hospitals and general hospitals offer physiotherapy and 
palliative care. Very few of the facilities offer chemotherapy or radiotherapy. Of regional referral 
hospitals, 2 (15.4%) offer chemotherapy and 1 (7.7%) offers radiotherapy. 
 The majority of regional referral hospitals and general hospitals offer individual (69.2% 
and 63.0%) and group (92.3% and 66.7%) NCD education, foot care for diabetic patients (61.5% 
and 55.6%), and nutrition advice for all patients (92.3% and 85.2%). However, very few of the 
facilities offer NCD patient cards or provide NCD Information, Education and Communication 
(IEC) materials. Ten (77.0%) of regional referral hospitals offer patient treatment plans, self-
management support, and links to peer/social support. Less of the general hospitals and health 
center IVs offer these services. Specifically, only 11.1% of general hospitals and 28.3% of health 
center IVs offer patient treatment plans. Even fewer of the health center IVs offer self-
management support (14.3%) and links to peer/social support (21.4%). (Table 8) 
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 WHO lists evidence-based clinical protocols as essential for implementing NCD 
interventions. Very few Ugandan health facilities have guidelines for the management of 
common NCDs. Some of the personnel who were interviewed noted that few members of the 
staff have access to NCDs guidelines, so many “patients will not be diagnosed” and health 
professionals dealing with NCDs patients “are not very confident because they have forgotten 
the key message they should follow in managing that patient.” 
 Specifically, only 30.8% of regional referral hospitals, 14.8% of general hospitals, and 
7.1% of health center IVs have access to diabetes management guidelines. Even fewer have 
access to guidelines on hypertension management, and none of the regional referral hospitals or 
health center IVs have access to guidelines on hyperlipidemia management and tobacco 
screening and treatment. Less than a quarter of each type of health facility has access to 
guidelines on the screening and treatment of cancer, mental health, or sickle cell disease. Similar 




Lack of equipment was a common issue in all of the health facilities. Many of the health 
workers commented on the lack of simple tools that help to prevent and manage NCDs during 
the interviews and administration of the needs assessment survey. For example, in one of the 
interviews, a health worker said, “You are limited somehow for particular investigations. You 
saw for diabetes we have glucometers around, but sometimes it’s not everywhere: in the whole 
hospital you might get one. Those basic machines for investigations, sometimes even for 
observations…it can limit the way you want to do very efficient clinical work.” 
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This section summarizes the availability of NCD-related equipment in the health 
facilities. While the regional referral hospitals and general hospitals had these items of 
equipment spread out among the different wards of the facilities, these items were usually only 
located in the medical out patient department (MOPD) of the health center IVs. 
The WHO essential tools for implementing essential NCD interventions in primary care 
include: patient clinical record, medical information register, and audit tools. While over half of 
the regional referral hospitals reported having patient files (61.5%), the minority of general 
hospitals (44.4%) and health center IVs (35.7%) did. Some of the health facilities did not have 
adequate space (such as a file cabinet, cupboard, or stage space) to keep their patients files. Only 
69.2% of regional referral hospitals, 66.7% of general hospitals, and 42.9% of health center IVs 
reported having space for files. The majority of the health facilities did not have NCD registers. 
For regional referrals, 46.2% had a register for new cases only, 46.2% for follow-up cases only, 
and 15.4% for admission only. For general hospitals, 51.9% had a register for new cases, 48.1% 
for follow-up cases, and 48.1% for admission cases. For health center IVs, 42.9% had a register 
for new cases, 42.9% for follow-up cases, and 50.0% for admission cases. 
The essential technologies that WHO recommends are: thermometer, stethoscope, blood 
pressure measurement device, measurement tape, weighing machine, peak flow meter, spacers 
for inhalers, glucometer, blood glucose test strips, urine protein test strips, and urine ketone test 
strips. Some of the facilities within each health facility type lacked these essential technologies. 
For example, 53.8% of regional referral hospitals had at least one thermometer in the facility. 
Similarly, 51.9% of general hospitals and 57.1% of health center IVs did. The numbers are 
similar for stethoscopes: 1.5% of regional referral hospitals, 59.3% of general hospitals, and 
50.0% of health center IVs had at least one stethoscope. Less than half of all regional referral 
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hospitals and general hospitals had at least one of each type of blood pressure machine (mercury 
sphygmomanometer, aneroid, and automated). WHO recommends, for facilities with 
nonphysician health workers, a blood pressure measurement device with digital reading. Five out 
of the 14 health center IVs (35.7%) had at least one automated blood pressure machine. Six 
(42.9%) had at least one aneroid machine, and six (42.9%) had at least one mercury 
sphygmomanometer. Which health center IVs had these machines is unknown at this time. The 
facilities also lacked blood pressure cuffs – 30.8% of regional referral hospitals, 33.3% of 
general hospitals, and 57.1% of health center IVs reported having at least one standard blood 
pressure cuff in the facility. The numbers were worse for pediatric cuffs –7.7% of regional 
referral hospitals, 11.1% of general hospitals, and 21.4% of health center IVs reported having at 
least one pediatric cuff in the facility. Just over a half of all types of health facilities had at least 
one measuring tape. Specifically, 53.8% of regional referral hospitals, 51.9% of general 
hospitals, and 50.0% of health center IVs had at least one.  
WHO does not specify which type of scale is preferred. In this case, “bathroom type” 
meant the small, simple, automated scale. “Hospital type” meant the scales that have a die-cast 
balance beam scale at eye level. More facilities had at least one “bathroom type” weighing 
machine than “hospital type.” Only 30.8% of regional referral hospitals, 40.7% of general 
hospitals, and 28.6% of health center IVs had at least one hospital type weighing scale, compared 
to 53.8% regional referral hospitals, 55.6% of general hospitals, and 57.1% of health center IVs 
that had at least one bathroom type scale. 
Peak flow meters were not included in the needs assessment because MoH knew it was 
unlikely for the facilities to have them. Very few of the facilities had spacers for inhalers. Only 3 
regional referral hospitals (23.1%), 1 general hospital (3.7%), and 1 health center IV (7.1%) had 
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them. The number of facilities with blood glucose meters (glucometer) was higher, but not 
sufficient. Of the facilities surveyed, 61.5% of regional referral hospitals, 74.1% of general 
hospitals, and 42.9% of health center IVs had at least one glucometer. Facilities were asked if 
they had multiple urine testing strips, which test both urine protein and urine ketone. Three 
regional referral hospitals (23.1%), 2 general hospitals (7.4%), and 2 health center IVs (14.3%) 
had multiple tests for their use.  
WHO provides additional technologies that are essential when resources permit. Two 
technologies on this list are: nebulizer and tuning fork. Very few of the health facilities had these 
technologies. Specifically, 1 regional referral hospital (7.7%), 4 general hospitals (14.8%), and 2 
health center IVs (14.3%) had at least one set of tuning forks. The proportion of facilities that 
had at least one nebulizer was slightly better: 30.8% of regional referral hospitals, 11.1% of 
general hospitals, and 14.3% of health center IVs. (Table 10) 
More than half of each type of health facility had an ultrasound scan, but not all of them 
are functional. For example, 84.6% of regional referral hospitals had an ultrasound scan, but only 
54.6% were functional. A few of the regional referral hospitals had an echocardiography 
machine (23.1%) and electrocardiogram (ECG) machine (23.1%), and even fewer of the general 
hospitals (3.7% and 14.8%, respectively) had these. Similarly, only 33.3% of the 
echocardiography and ECG machines in regional referral hospitals were functional. 
Most of the regional referral hospitals (76.9%) and general hospitals (81.5%) had X-ray 
machines, but only a little over half of them were functional (60.0% and 54.6%, respectively). In 
comparison, 2 health center IVs had X-ray machines, but none of them were functional.  
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Even fewer health facilities had more advanced equipment. For example, 38.5% of 
regional referral hospitals had Doppler and 15.4% had CT-scan. None of the general hospitals or 
health center IVs had a CT-scan, and 1 general hospital had a non-functional Doppler. 
Few health facilities have a reliable power supply (usually hydro-electricity). 
Specifically, 53.9% of regional referral hospitals, 63.0% of general hospitals, and 28.6% of 
health center IVs had a reliable power supply. More than half of them did have an alternative 
power supply (usually solar or a generator). Although it was not always functional, 69.2% of 
regional referral hospitals, 74.1% of general hospitals, and 64.3% of health center IVs had an 




A major challenge that health personnel said they face in their facilities every day was 
not knowing if the pharmacy would have the drug they prescribed to a patient. When asked if 
they receive the types of drugs and quantity of drugs they request, more than half of the 
pharmacists at each type of health facility said no (Table 12). The needs assessment included a 
section on the availability and stockout experiences of specific classes of drugs. The list of drugs 
was based off of the WHO core list of NCD medicines. Pharmacists were asked whether they 
had particular classes of drugs available on the day the needs assessment was conducted, and 
whether or not they had experienced a stockout in the last quarter or last year of the drugs. A 
stockout was defined as a period of time when the pharmacy’s inventory of a drug was 
exhausted. 
Regional referral hospitals’ pharmaceutical drugs are restocked every two months. 
Overall, regional referral hospitals are well-stocked with anti-hypertensives with the exception of 
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beta-blockers. Only 53.8% of the facilities carry beta-blockers, and 23.1% experienced a 
stockout in the last quarter. The regional referral hospitals are also generally well-stocked with 
diabetic drugs, except for thiazolidinediones (7.7%). Twelve had biguanides (i.e. Metformin) 
available at the time of the needs assessment (92.3%), and none of the hospitals had had a 
stockout in the last year. The type of insulin carried varies by regional referral hospital. 
Specifically, 61.5% carry ultra short-acting, 69.2% carry short-acting, 76.9% carry intermediate, 
and 84.6% carry long-acting. Due to a recent national changeover of the concentration of insulin 
to U100, facilities were also asked about its availability. Ten of the regional referral hospitals 
had U100 (76.9%). As for other drugs, regional referral drugs are generally well-stocked with 
folic acid (92.3%) and cardiac aspirin (84.6%). However, only 15.4% carry statins, and 30.8% 
had experienced a stockout in the last quarter. The same amount (30.8%) of regional referral 
hospitals experienced a stockout of cardiac aspirin in the last year. 
More than half of general hospitals carry the anti-hypertensive drugs. However, 37.0% 
experienced a stockout of beta-blockers in the last quarter. For diabetic drugs, 88.9% have 
biguanides available, and 81.5% have sulfonylureas. More than half of the hospitals (63.0%) 
have U100 concentration of insulin. Only 2 general hospitals have statins available (7.4%). 
While 59.3% have cardiac aspirin, 22.2% had experienced a stockout in the last year.  
While all of the health center IVs had calcium channel blockers and biguanides available, 
35.7% experienced a stockout of both drugs in the last year. Less than half carry ACE inhibitors 
(42.9%), thiazolidinediones (7.1%), dipeptidyl peptidase-4 inhibitors (7.1%), U100 (14.3%), 
statins (21.4%), and cardiac aspirin (35.7%). Five (35.7%) of the health center IVs experienced a 
stockout of cardiac aspirin in the last year. Additionally, only a few of the health center IVs carry 
insulin. Only 14.3% have U100, and by type, 21.4% carry ultra short-acting, 35.7% carry short-
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acting, 21.4% carry intermediate, and 21.4% carry long-acting. Of those who do carry insulin, 
most of them did not experience a stockout in the past year. 
The availability of a refrigerator in the pharmacy was also assessed. While the 
proportions of regional referral hospitals and general hospitals that had a refrigerator were high 
(92.3% and 70.4%, respectively), only 21.4% of health center IVs had a refrigerator to store 
drugs in their pharmacy. (Table 13) 
 
H. Laboratory services 
 
All of the regional referral hospitals and general hospitals and 12 of the health center IVs 
(86%) had an on-site laboratory. The facilities had high proportions of access to a centrifuge, 
microscope, and refrigerator in the laboratories.  
In general, regional referral hospitals had the highest proportion of facilities that had 
general tests, such as hemoglobin, complete blood count and differential, electrolytes, renal 
function tests, liver function tests, lipid profile, and urinalysis, available. Most of the regional 
referral hospitals and health center IVs were able to do hemoglobin tests (88.9% and 78.6%) and 
urinalysis (96.3% and 92.9%). Less than half of the regional referral hospitals had available tests 
for electrolytes (40.7%) and lipid profile (33.3%).  
Most of the health facilities were able to do random blood glucose testing. Only 30.8% of 
regional referral hospitals and 11.1% of general hospitals had urine microalbumin tests. Very 
few of the regional referral hospitals and general hospitals were able to do cancer tests.  
Of note are the tests that more general hospitals have available than regional referral 
hospitals. Specifically, 18.5% of general hospitals and no regional referral hospitals have 
available hemoglobin A1c tests for diabetes, and 14.8% of general hospitals and no regional 
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referral hospitals have hemoglobin electrophoresis for sickle cell disease. Similarly, a higher 
proportion of general hospitals were recorded to have thick and thin film for malaria than 
regional referral hospitals. These statistics are unexpected, due to the larger capacity of regional 
referral hospitals, and may or may not be representative of the true proportions. (Table 14) 
  
I. Health care providers’ confidence and attitudes 
 
Description of Sample: 
The majority of health personnel individually surveyed on their confidence and attitudes 
of NCD management were nurses and midwives (27.6%). Nursing officers (15.5%), clinical 
officers (13.8%), medical officers (16.4%) and physicians (8.6%) also completed the individual 
survey. Personnel who did not fit into these five categories were classified as “Other”, as well as 
those who filled out the survey but did not specify their cadre. (Table 15) 
 
Confidence in NCD Management: 
The personnel’s confidence in managing hypertension, diabetes, and high cholesterol 
(p<0.001 for all three) was significantly associated with the type of cadre of personnel. The 
majority of nurses and midwives felt only somewhat confident in their skills to manage 
hypertension (56.3%) and diabetes (46.9%). Almost 72% were not at all confident in managing 
high cholesterol. Nursing officers and clinical officers followed a similar pattern. They were 
confident in managing hypertension (38.9% and 62.5%), somewhat confident in managing 
diabetes (38.9% and 56.3%), and not at all confident in managing high cholesterol (61.1% and 
75.0%). Medical officers and physicians were more confident in their abilities to manage NCDs. 
A little over half of medical officers were confident in managing hypertension and diabetes 
(52.6% and 57.9%), while the majority of physicians were very confident (80.0% and 80.0%). 
 32 
The majority of medical officers were either somewhat confident (31.6%) or not at all confident 
(31.6%) in managing cholesterol, while 60.0% of physicians were very confident. 
The personnel’s confidence in screening for cervical cancer (p=0.021) and breast cancer 
(p=0.037) was also significantly associated with the type of cadre. The majority of nurses and 
midwives, nursing officers, and clinical officers were not at all confident in screening for 
cervical cancer (68.8%, 66.7%, and 62.5%, respectively), while medical officers were mostly 
somewhat confident (31.6%). Sixty percent (60.0%) of physicians were either very confident or 
confident in their ability to screen for cervical cancer. These confidence levels are similar for 
screening for breast cancer. The majority of nurses and midwives and clinical officers are not at 
all confident in screening for breast cancer (46.9% and 43.8%), while nursing officers are 
somewhat confident (50.0%). The majority of both medical officers and physicians are very 
confident in screening for breast cancer (31.6% and 40.0%). 
The personnel’s confidence in diagnosing and managing asthma, depression and other 
mental health disorders, and sickle cell disease was significantly associated with the type of 
cadre. Nurses/midwives and nursing officers were confident in diagnosing and managing asthma 
(50.0% and 72.2%), but somewhat confident in diagnosing and managing depression and other 
mental health disorders (34.4% and 44.4%) and sickle cell disease (48.4% and 44.4%). The 
majority of clinical officers were confident in diagnosing and managing asthma (50.0%), but 
somewhat confident for depression and other mental health disorders (50.0%) and sickle cell 
disease (37.5%). Medical officers and physicians were very confident in diagnosing and 
managing asthma (63.2% and 70.0%). Medical officers were somewhat confident in diagnosing 
and managing depression and other mental health disorders (42.1%) and confident for sickle cell 
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disease (57.9%). Physicians were confident in diagnosing and managing depression and other 
mental health disorders (77.8%) and very confident for sickle cell disease (55.6%). 
The personnel’s confidence for the treatment of tobacco and alcohol abuse was not 
significantly associated with the type of cadre. Each cadre was less confident than in many of the 
other areas of NCD management, and the trend of confidence levels among the cadre groups was 
reversed compared to the areas discussed above. For example, while physicians usually were 
confident or very confident in their skills to manage NCDs, the majority of physicians were not 
at all confident in treating tobacco abuse or alcohol abuse (55.6% and 38.9%). In comparison, 
46.9% of nurses/midwives and 38.9% of nursing officers felt confident in treating alcohol abuse. 
(Table 16) 
 
Attitudes on NCD Management: 
The attitudes on NCD management were not significantly associated with the type of 
cadre. The majority of the personnel agreed that patients receive better care for chronic medical 
conditions if they have a designated primary care provider. However, all health personnel 
disagreed that there are effective depression treatments that can be provided by a primary care 
physician in their facility. The majority of nurses and wives (65.5%), nursing officers (80.0%), 
medical officers (62.5%), and physicians (100.0%) agreed that their clinical training prepared 
them adequately to manage chronic diseases, but most clinical officers disagreed (75.0%). 
Nurses and midwives (78.6%), clinical officers (75.0%), and physicians (71.4%) agreed that a 
doctor can influence whether a patient successfully quit smoking, but nursing officers and 
medical officers had equal numbers of agreement and disagreement. Most personnel agreed that 
they are able to spend the time they need to provide good medical care for their patients with 
chronic disease. Specifically, nurses and midwives (80.0%), nursing officers (66.7%), medical 
 34 
officers (56.3%), and physicians (71.4%) agreed, while half of clinical officers did not. While the 
majority of the different personnel cadres agreed that their facility has the capacity to manage 
chronic disease, medical officers had equal numbers of agreement and disagreement. (Table 17) 
 
Comments: 
Many of the personnel commented on the need for further training in NCDs. A clinical 
officer from Kaabong Hospital in the commented, “Management of communicable diseases has 
been challenging because of the knowledge gap at the primary level where most of the service 
providers use the basic knowledge they get from their training.” A nursing officer from the same 
hospital said, “There are no staff trained on management of chronic conditions. We task the 
ministry to train nurses on the following conditions: cancer of the cervix, sickle cell disease, etc. 
MOH should strengthen capacity building for health workers in hard to reach areas and provide 
scholarships for specific courses.”  
Some of the personnel also commented that understaffing and lack of equipment and 
medicines inhibited their capacity to manage NCDs. A nurse in Lyantonde Hospital commented 
that the hospital has insufficient staff, thus they are “handling NCD patients in general OPD.” 
Another nurse in Tororo Hospital commented that staff members are not interested in learning 
more about NCD management because most are volunteers and are not paid. A medical officer 
from Bududa Hospital said, “There is understaffing and lack of critical cadres. Basic 
investigations are not done due to a lack of skilled officers and lab reagents.” Other personnel 
also noted the lack of laboratory reagents and medicines. For example, a nurse in Masindi 
Hospital commented that there is a lack of good follow-up of NCDs because it is “difficult to 
manage cases – no glucometers and drugs for diabetes and others.” A physician in Hoima 
Regional Referral Hospital said that the capacity to manage NCDs is limited by: “no Hb 
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electrophoresis machine, stock out of strips to monitor diabetes, shortage of staff, stock out of 
medicines (e.g. insulin and oral morphine), limited space in OPD to run specialized out patient 
clinics.” Several other personnel also mentioned the lack of space. A staff member in Pallisa 
Hospital said that the reason the hospital only ran a diabetes clinic once a month was because of 
“lack of staff, inadequate space to run a diabetes clinic.”  
 
J. Referral system 
 
A small proportion of the health facilities had access to protocols for the management and 
referral of NCD patients. Specifically, 15.4% of regional referral hospitals, 29.6% of general 
hospitals, and 7.1% of health center IVs have access t the resource. Most of the facilities had 
access to an outgoing referral form, but only 46.2% of regional referral hospitals and 26.0% of 
general hospitals had access to a receiving referral form. The facilities also lack ambulances. 
Half of the health center IVs and regional referral hospitals have available transport to the next 
facility (50.0% and 53.8%, respectively). More general hospitals have a register to monitor 
follow-up and gather statistics on referrals (both outgoing and receiving) than health center IVs 
and regional referral hospitals. For example, 70.4% of regional referral hospitals have access to 
this outgoing register, compared to 42.9% of health center IVs and 46.2% of general hospitals. 
Additionally, only a few of the facilities had a program that integrates NCDs support supervision 
and capacity building in lower health facilities. Specifically 23.1% of regional referral hospitals, 






K. Community engagement 
 
The majority of each type of health facility does not engage in community activities, 
especially NCDs activities. For example, only 46.2% of regional referral hospitals communicate 
about disease states through media, gatherings, IEC, and/or village health teams, 7.7% have 
formal linkages to the community and regular community meetings on NCDs, 7.7% have 
partnerships with community organizations that focus on NCDs, and 15.4% engage with the 
community in patient follow-up. These proportions are similar for general hospitals and health 




The majority of regional referral hospital diabetes clinics are linked with the Uganda 
Diabetic Association (UDA). While 61.5% of them have a branch of the UDA in the facility, 
75.0% of these branches are functional, meaning regular meetings are held, minutes, work plans, 
and reports are available.  
Of the 7 general hospitals (26.0%) that have a UDA branch, 71.4% of them are 
functional. Of the 2 health center IVs (14.3%) that have a UDA branch, only 1 of them is 















A. Summary of findings 
 
Results of this assessment of the capacity of Ugandan health facilities, personnel and 
resources to address NCDs demonstrate some strengths, but there remain significant gaps in the 
availability of human resources and NCD training, equipment, medicines, laboratory tests, 
accurate data, and NCD community activities. Although there is variability among the different 
types of health facilities, none of them meet the WHO standards for essential tools and medicines 
to implement effective NCDs interventions.  
As expected, the regional referral hospitals fare the best compared to general hospitals 
and health center IVs, but they still report concerning numbers of facilities that lack basic and 
effective NCD prevention and control equipment, medicines, and standard guidelines. They also 
lack basic health personnel trained in NCDs, such as diabetic and psychiatric nurses, and staff 
that provide NCD counseling and education.  
In general, Ugandan health facilities lack basic NCD screening and prevention services. 
Screening is important to catch patients with modifiable risk factors early on before they develop 
a severe NCD. Despite this, less than half of all health facilities have the essential equipment and 
tests to screen for such risk factors.  
The health facilities also had poor to moderate quality of care of NCDs. Very few had 
standard guidelines to follow for managing specific NCDs and registers to keep track of NCD 
patients. All facilities experienced concerning numbers of stockouts of essential NCD medicines 
within the last year. Most of the providers demonstrated a lack of confidence in screening and 
managing NCDs. Limited training, heavy workloads, and a lack of equipment and medicines 
were often named as hindrances to performing effective NCD prevention and control.   
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The assessment also highlights the need to strengthen essential health system functions to 
improve NCD care. They lack a strong referral system to send NCD patients to higher-level 
facilities. Additionally, there is no NCD health information system. Health facilities cannot 
reliably measure NCD incidence, prevalence, mortality, or care coverage, so the true state of 




This needs assessment had several limitations. To begin with, the sample of the needs 
assessment did not include all of the general hospitals or health center IVs. While it did survey 
many of these facilities, the sample was not randomized. Consequently, the results from this 
needs assessment may not be a general representative of general hospitals and health center IVs 
throughout the country. Additionally, the needs assessment survey itself involved many steps and 
questions, and therefore was burdensome for the MoH staff to conduct and for the health 
facilities to complete. For example, the equipment section asked about the availability and 
number of a certain type of equipment for each clinic. Given the resource-limited settings, it was 
often sufficient to ask how many items were available in the hospital overall. The health facility 
staff members were under time constraints, and may not have been able to fully and accurately 
complete each section. 
The “gold standard” of conducting a needs assessment is time-intensive direct 
observation.29 However, due to time and funding constraints, the survey was completed in a few 
hours by asking staff members about the availability and number of equipment, laboratory tests, 
guidelines, etc. There was no standardized method of conducting the needs assessment, and the 
quality and accuracy of the data collected depended on the staff available on the particular day of 
the MoH visit. The type of personnel who helped to complete the survey varied at each facility, 
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meaning their levels of knowledge and experience also varied. This may have had an effect on 
the accuracy of reporting. Sometimes the assessment was completed by manually counting the 
number of these items, but this was not the common method. Therefore, future improvements for 
similar needs assessment surveys would include randomized samples, standardized data 
collection methods, and time-intensive direct observation or manual spot checks.  
The accuracy and availability of data were also limitations to the analysis section of this 
report. For example, in some cases, regional referral hospitals unexpectedly had lower 
proportions of available pharmaceutical drugs and laboratory tests than general hospitals. 
Perhaps this statistic is true, but it seems counterintuitive and may be due to inaccurate reporting 
from the reasons listed above as well as many others. 
The data requested was often unavailable. Only six regional referral hospitals were able 
to report how many NCD patients they had. This lack of data made reporting representative 
statistics difficult. Improvements in NCD data collection are needed to provide an accurate 
representation of the magnitude of NCDs in Uganda. 
Even with these limitations, the amount of data collected from this needs assessment is 
vast in magnitude and much more information can be pulled from it. This report is the beginning 
of the assessment, and there is great potential for finding significant differences between the 
capacities of the health facilities, examining differences between urban and rural facilities, 
assessing the exact number of equipment availability per clinic, and much more. The data 
collected from this needs assessment can and should be used for further analysis to develop the 







The results of this assessment highlight critical gaps in availability and use of essential 
NCD health services in Ugandan regional referral hospitals, general hospitals, and health center 
IVs. They demonstrate the need for Uganda to scale-up low cost, high impact NCD interventions 
and strengthen the capacity of health personnel to reduce NCD disability and death in the 
country. This report can aid the Ugandan Ministry of Health and partners to develop action steps 
to target key areas of improvement and fill in the gaps. The improvement of the capacity of 
health facilities and personnel to effectively detect and manage NCDs can yield significant 
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Table 1. Health facilities surveyed by area and support 
 
Area Support  












13 8 (61.5) 1 (7.7) 6 (46.2) 0 (0.0) 
General Hospital 27 6 (22.2) 16 (59.3) 12 (44.4) 1 (3.7) 
Health Center IV 14 3 (21.4) 9 (64.3) 6 (42.9) 0 (0.0) 
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Table 2. Health care personnel availability and mean by health facility type 
 









No. reporting at 
least 1 staff 






No. reporting at 
least 1 staff 






No. reporting at 
least 1 staff 







Family physician 3 (23.1) 1.7 (± 1.2) 2 (7.4) 1.0 (± 0.0) 0 (0.0) -- 
Medical officer 10 (76.9) 5.3 (± 4.3) 22 (81.5) 3.2 (±1.7) 11 (78.6) 1.2 (±0.7) 
Clinical officer 13 (100.0) 10.6 (± 3.9) 24 (88.9) 5.6 (±2.4) 11 (78.6) 1.2 (±1.3) 
Specialist Physician 
Specialist physician 7 (53.8) 1.3 (± 0.5) 0 (0.0) -- 0 (0.0) -- 
Cardiologist 1 (7.7) 1.0 (± 0.0) 2 (7.4) 5.0 (± 0.0) 3 (21.4) 1.7 (±0.6) 
Endocrinologist/ 
diabetologist 
1 (7.7) 1.0 (± 0.0) 1 (3.7) 2.0 (± 0.0) 0 (0.0) -- 
General surgeon 9 (69.2) 1.8 (± 0.9) 3 (11.1) 1.7 (±1.2) 1 (7.1) 1.0 (± 0.0) 
Neurologist 0 (0.0) -- 1 (3.7) 1.0 (± 0.0) 0 (0.0) -- 
OB/GYN 8 (61.5) 3.0 (± 1.7) 4 (14.8) 1.25 (±0.5) 0 (0.0) -- 
Oncologist 0 (0.0) -- 0 (0.0) -- 0 (0.0) -- 
Ophthalmologist 3 (23.1) 1.3 (± 0.6) 1 (3.7) 1.0 (± 0.0) 0 (0.0) -- 
Pediatrician 7 (53.8) 2.1 (± 0.7) 1 (3.7) 1.0 (± 0.0) 0 (0.0) -- 
Pathologist 1 (7.7) 1.0 (± 0.0) 0 (0.0) -- 0 (0.0) -- 
Physiotherapist 8 (61.5) 2.6 (± 1.4) 6 (22.2) 1.0 (± 0.0) 0 (0.0) -- 
Psychiatrist 1 (7.7) 1.0 (± 0.0) 1 (3.7) 1.0 (± 0.0) 3 (21.4) 1.0 (± 0.0) 
Pulmonologist 0 (0.0) -- 0 (0.0) -- 0 (0.0) -- 
Radiologist 6 (46.2) 1.8 (± 1.3) 0 (0.0) -- 0 (0.0) -- 
Vascular surgeon 1 (7.7) 1.0 (± 0.0) 0 (0.0) -- 0 (0.0) -- 
Nurse 
Nurse - general 10 (76.9) 47.8 (± 22.2) 22 (81.5) 31.5 (±13.7) 13 (92.9) 5.4 (±1.7) 
Nurse - diabetic 4 (30.8) 3.0 (± 1.0) 7 (25.9) 1.4 (±0.8) 2 (14.3) 2.5 (±2.1) 
Nurse - psychiatric 9 (69.2) 3.9 (± 3.3) 20 (74.1) 1.5 (±0.7) 8 (57.1) 1.8 (±0.5) 
Midwife 13 (100.0) 32.9 (± 21.8) 24 (88.9) 15.1 (±8.7) 13 (92.9) 4.2 (±1.3) 
Health technician 




11 (84.6) 2.6 (± 1.3) 13 (48.1) 1.4 (±1.7) 2 (14.3) 1.0 (± 0.0) 




7 (53.8) 2.6 (± 0.9) 7 (25.9) 5.7 (±0.5) 2 (14.3) 1.9 (± 2.1) 
NCDs Counselor 0 (0.0) -- 1 (3.7) 2.0 (± 0.0) 0 (0.0) -- 
Foot care specialist 1 (7.7) 1.0 (± 0.0) 0 (0.0) -- 0 (0.0) -- 
Medical social 
worker 
6 (46.2) 1.6 (± 0.9) 11 (40.7) 1.1 (±0.3) 0 (0.0) -- 
NCD (DM) educator 1 (7.7) 1.0 (± 0.0) 1 (3.7) 6.0 (± 0.0) 0 (0.0) -- 
Nutritionist 8 (61.5) 1.3 (± 0.5) 7 (25.9) 1.0 (± 0.0) 0 (0.0) -- 
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Table 3. Facility-based NCDs prevalence by health facility type 
 
Mean Cases in Last Financial Year  





















118513   87891   72633   
Number of NCDs 
patients 
20474 17.28%  5434 6.18%  1300 1.79%  
Diabetes (total) 1788 1.51% 8.73% 530 0.60% 9.75% 143 0.20% 11.00% 
Diabetes (adult) 1674 1.41% 8.18% 2582 2.94% 47.52% 139 0.19% 10.69% 
Diabetes 
(children) 






















Cancer (total) 280 0.24% 1.37% 22 0.03% 0.40% 7 0.01% 0.54% 
Breast cancer 16 0.01% 0.08% 3 0.00% 0.06% 0 0.00% 0.00% 
Cervix cancer 51 0.04% 0.25% 10 0.01% 0.18% 6 0.01% 0.46% 
Prostate cancer 15 0.01% 0.07% 8 0.01% 0.15% 0.5 <0.01% 0.04% 
Lung cancer 3 <0.01% 0.01% 1 <0.01% 0.02% 0 0.00% 0.00% 
Liver cancer 60 0.05% 0.29% 1 <0.01% 0.02% 1 <0.01% 0.08% 
Kaposi’s 
sarcoma 
22 0.02% 0.11% 2 0.00% 0.04% 1 <0.01% 0.08% 
Heart disease 
(total) 
603 0.51% 2.95% 152 0.17% 2.80% 30 0.04% 2.31% 
Heart disease 
(adults) 
435 0.37% 2.12% 166 0.19% 3.05% 105 0.14% 8.08% 
Heart disease 
(children) 
33 0.03% 0.16% 1 <0.01% 0.02% 0 0.00% 0.00% 
Asthma 860 0.73% 4.20% 319 0.36% 5.87% 188 0.26% 14.46% 
COPD  118 0.10% 0.58% 3712* 4.22% 68.31% 5156* 7.10% 396.62% 
Stroke 22 0.02% 0.11% 7 0.01% 0.13% 1 <0.01% 0.08% 
Renal disease 53 0.04% 0.26% 8 0.01% 0.15% 0 0.00% 0.00% 
Mental health 
disorder 
1810 1.53% 8.84% 362 0.41% 6.66% 86 0.12% 6.62% 
Sickle cell 
disease 
467 0.39% 2.28% 23 0.03% 0.42% 14 0.02% 1.08% 
Injury (road 
traffic accident) 
545 0.46% 2.66% 344 0.39% 6.33% 44 0.06% 3.38% 
Injury (gender-
based violence) 
56 0.05% 0.27% 71 0.08% 1.31% 7 0.01% 0.54% 
Injury (trauma 








Alcohol-related 83 0.07% 0.41% 34 0.04% 0.63% 8 0.01% 0.62% 
Tobacco-related 69 0.06% 0.34% 10 0.01% 0.18% 5 0.01% 0.38% 
*Given the estimated prevalence of COPD in Uganda, these statistics are unlikely and are probably due to reporting 
error.
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Table 4. Facility-based NCDs prevalence for regional referral hospitals 
 
Recorded Cases in Last Financial Year 
N (%)* 
 
Arua Gulu Hoima Jinja Kabale Lira Masaka Mbale Mbarara Mityana Moroto Mubende Soroti 
Number of 
overall patients 
172945  155654 54200 112541 21509 139660 107250 139690 60683 55743 89653 121629 
Number of 
NCDs patients 































859 (1.42) 103 
(0.19) 
2190 (2.44) 503 
(0.41) 






















 0 (0.0) 0 (0.0) 5 (<0.01) 183 
(0.17) 























84 (0.14) 155 
(0.28) 









 0 (0.0) 0 (0.0) 80 (0.06)  114 (0.08) 0 (0.0) 3 (<0.01)   43 (0.04) 












568 (0.41) 4 (<0.01) 3 (<0.01) 21 (0.02) 103 
(0.09) 
Breast cancer 17 
(0.01) 
 4 (<0.01) 16 
(0.03) 
24 (0.02) 9 (0.04) 41 (0.03) 28 (0.03) 41 (0.03) 0 (0.0) 1 (<0.01) 5 (<0.01) 14 (0.01) 
Cervix cancer 19 
(0.01) 
  54 
(0.10) 




96 (0.09) 112 (0.08) 2 (<0.01) 1 (<0.01) 11 (0.01) 67 (0.06) 
Prostate cancer 6 
(<0.01) 
  30 
(0.06) 
12 (0.01) 15 
(0.07) 
36 (0.03) 17 (0.02) 38 (0.03) 0 (0.0) 0 (0.0) 5 (<0.01) 12 (0.01) 
Lung cancer      0 (0.0) 10 
(<0.01) 
 11 (<0.01) 0 (0.0)  0 (0.0) 0 (0.0) 
Liver cancer 255 
(0.15) 





 1 (<0.01) 8 (0.02) 2 (<0.01) 32 
(0.15) 














































28 (0.03) 121 (0.09) 0 (0.0) 0 (0.0)  40 (0.03) 
Asthma 919 
(0.53) 










745 (0.53) 157 (0.26) 98 (0.18) 386 (0.43) 710 
(0.58) 
COPD     95 
(0.18) 
  0 (0.0)     0 (0.0) 377 
(0.31) 








15 (0.01) 0 (0.0) 0 (0.0) 10 (0.01) 42 (0.04) 
Renal disease       110 
(0.08) 



















205 (0.34) 140 
(0.25) 

































  19 (0.03) 18 (0.03) 97 (0.11) 2 (<0.01) 
Injury (trauma 


















539 (0.89) 964 
(1.73) 























92 (0.07)   4 (<0.01) 1 (<0.01) 38 (0.04) 26 (0.02) 
* Due to the number of regional referral hospitals that could not report total number of NCDs patients, the percentages for specific cases are number of cases per 
overall total cases. 
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Table 5. HIV prevalence by health facility type 
 













































Jinja 5600 1600 (28.6) 4000 (71.4)    




Mbarara 9641 3385 (35.1) 6256 (64.9) 1745 (18.1) 1593 (16.5) 1848 (19.2) 
Bududa 753 243 (32.3) 510 (67.7) 302 (40.1) 282 (37.5) 225 (29.9) 
Iganga 4619 1644 (35.6) 2975 (64.4) 1555 (33.7) 1082 (23.4) 949 (14.1) 




Kyenjojo 3935 1607 (40.8) 2328 (59.2) 970 (24.7) 729 (18.5) 944 (24.0) 
Budaka  700     
Dokolo       




Serere 2431 958 (39.4) 1473 (60.6)    
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Table 6. Health facilities that have NCDs clinics 
 
Regional Referral 
Hospitals that have clinic 
(N=13) 
 
General Hospitals that 
have clinic (N=27) 
 
Health Center IVs that 





N (%) N (%) N (%) 
 
Diabetes 11 (84.6) 15 (55.6) 3 (21.4) 
Hypertension 7 (53.9) 5 (18.5) 1 (7.1) 
Cancer 2 (15.4) 1 (3.7) 0 (0.0) 
Cardiology 2 (15.4) 1 (3.7) 0 (0.0) 
COPD 1 (7.7) 0 (0.0) 0 (0.0) 
Renal 2 (15.4) 0 (0.0) 0 (0.0) 
Sickle Cell 4 (30.8) 2 (7.4) 0 (0.0) 
OB/GYN 7 (53.9) 12 (44.4) 3 (21.4) 
Pediatrics 4 (30.8) 8 (29.6) 0 (0.0) 
HIV 7 (53.9) 17 (63.0) 4 (28.6) 
Surgery 5 (38.5) 3 (11.1) 0 (0.0) 
Medical Out Patient 7 (53.9) 25 (92.6) 9 (64.3) 
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Table 7. Review of clinics in regional referral hospitals  
 









Number that have 















Diabetes 11 (84.6) 9 (81.8) 9 (81.8) 5 (45.5) 
Hypertension 7 (53.9) 5 (71.4) 4 (57.1) 2 (28.6) 
Cancer 2 (15.4) 2 (100.0) 2 (100.0) 0 (0.0) 
Cardiology 2 (15.4) 1 (50.0) 2 (100.0) 0 (0.0) 
COPD 1 (7.7) 0 (0.0) 1 (100.0) 0 (0.0) 
Renal 2 (15.4) 1 (50.0) 2 (100.0) 0 (0.0) 
Sickle Cell 4 (30.8) 1 (25.0) 2 (50.0) 0 (0.0) 
OB/GYN 7 (53.9) 7 (100.0) 7 (100.0) 3 (42.9) 
Pediatrics 4 (30.8) 3 (75.0) 3 (75.0) 2 (50.0) 
HIV 7 (53.9) 5 (71.4) 4 (57.1) 3 (42.9) 
Surgery 5 (38.5) 4 (80.0) 4 (80.0) 1 (20.0) 
Medical Out 
Patient 
7 (53.4) 6 (85.7) 5 (71.4) 3 (42.9) 
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that offer service  
 
N (%) 
Health Center IVs 




Weight 13 (100.0) 26 (92.3) 13 (92.9) 
Height  8 (61.5) 15 (55.6) 5 (35.7) 
BMI 6 (46.1) 5 (18.5) 0 (0.0) 
Waist:Hip 4 (30.8) 2 (7.4) 0 (0.0) 
Screening 
Blood pressure  13 (100.0) 24 (88.9) 12 (85.7) 
Sickle cell screening* 4 (30.8) 16 (59.3) 6 (42.9) 
Cervical cancer 
screening (pap smear) 
9 (69.2) 14 (51.9) 8 (57.1) 
Breast cancer screening 7 (53.8) 11 (40.7) 4 (28.6) 
Prostate cancer screening 2 (15.4) 1 (3.7) 0 (0.0) 
Eye examination 5 (38.5) 12 (44.4) 5 (35.7) 
Record of family history 
of NCDs 
8 (61.5) 12 (44.4) 3 (21.4) 
Laboratory tests 
Blood glucose 11 (84.6) 23 (85.2) 11 (78.6) 
Oral Glucose Tolerance 
Test (OGTT) 
3 (23.1) 2 (7.4) 0 (0.0) 
Blood lipids 3 (23.1) 3 (11.1) 1 (7.1) 
Urinalysis 9 (69.2) 22 (81.5) 11 (78.6) 
Urine proteins  9 (69.2) 20 (74.1) 12 (85.7) 
Urine ketones  8 (61.5) 18 (66.7) 10 (71.4) 
Cytology/pathology 
services 
4 (30.8) 0 (0.0) 0 (0.0) 
Treatment 
Physiotherapy 8 (61.5) 11 (40.7) 1 (7.1) 
Palliative care 7 (53.8) 18 (66.7) 4 (28.6) 
Chemotherapy 2 (15.4) 1 (3.7) 1 (7.1) 
Radiotherapy 1 (7.7) 2 (7.4) 0 (0.0) 
NCD advice and support 
Individual patient NCD 
education 
9 (69.2) 17 (63.0) 5 (35.7) 
Group NCD education 12 (92.3) 18 (66.7) 4 (28.6) 
Foot care for diabetic 
patients 
8 (61.5) 15 (55.6) 2 (14.3) 
Nutrition advice for all 
patients 
12 (92.3) 23 (85.2) 11 (78.6) 
NCD patient card 3 (23.1) 1 (3.7) 2 (14.3) 
Provision of NCDs IEC 
materials 
4 (30.8) 2 (7.4) 2 (14.3) 
Patient treatment plans 10 (77.0) 3 (11.1) 4 (28.6) 
Self-management 
support 
10 (77.0) 13 (48.1) 2 (14.3) 
Peer/social support 
linkage 
10 (77.0) 10 (37.0) 3 (21.4) 
*Including sickle cell screening for newborns 
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that have guidelines  
 
N (%) 




Diabetes management 4 (30.8) 4 (14.8) 1 (7.1) 
Hypertension 
management  
3 (23.1) 3 (11.1) 1 (7.1) 
Hyperlipidemia 
management 
0 (0.0) 2 (7.4) 0 (0.0) 
Tobacco screening & 
treatment 
0 (0.0) 2 (7.4) 0 (0.0) 
Alcohol screening & 
treatment 
0 (0.0) 1 (3.7) 1 (7.1) 
Cancer (cervical, 
breast, prostate) 
screening & treatment 
3 (23.1) 2 (7.4) 2 (14.3) 
Mental health 
screening & treatment 
2 (15.4) 3 (11.1) 2 (14.3) 
Asthma management 2 (15.4) 2 (7.4) 1 (7.1) 
Sickle cell screening & 
management 
2 (15.4) 3 (11.1) 0 (0.0) 
Palliative care 2 (15.4) 6 (22.2) 1 (7.1) 
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Table 10. Equipment availability by health facility type 
 
Equipment No. of Regional 
Referral Hospitals that 
have at least one of 
equipment (N=13) 
N (%) 
No. of General 
Hospitals that have at 
least one of equipment 
(N=27) 
N (%) 
No. of HCIVs that 
have at least one of 
equipment (N=14) 
N (%) 
Basic Equipment and Tools 
Clinician table 11 (84.6) 24 (88.9) 13 (92.9) 
Nurses station/table 10 (76.9) 20 (74.1) 9 (64.3) 
Hand washing basin/sink 
with soap 
10 (76.9) 22 (81.5) 12 (85.7) 




9 (69.2) 18 (66.7) 6 (42.9) 
NCD Register  
New cases only 6 (46.2) 14 (51.9) 6 (42.9) 
Follow-up cases only 6 (46.2) 13 (48.1) 6 (42.9) 
Admission only 2 (15.4) 13 (48.1) 7 (50.0) 
Screening Equipment 
Thermometer 7 (53.8) 14 (51.9) 8 (57.1) 
Stethoscope 8 (61.5) 16 (59.3) 7 (50.0) 
Blood pressure machine: 
Mercury 
sphygmomanometer 
6 (46.2) 9 (33.3) 6 (42.9) 
Blood pressure machine: 
Aneroid 
6 (46.2) 7 (26.0) 6 (42.9) 
Blood pressure machine: 
Automated 
5 (38.5) 13 (48.1) 5 (35.7) 
BP cuffs: Standard (25 cm 
x 12 cm) 
4 (30.8) 9 (33.3) 8 (57.1) 
BP cuffs: Alternate (36 cm 
x 12 cm) 
0 (0.0) 1 (3.7) 1 (7.1) 
BP cuffs: Pediatric 1 (7.7) 3 (11.1) 3 (21.4) 
Measuring tapes 7 (53.8) 14 (51.9) 7 (50.0) 
Blood glucose meter 8 (61.5) 20 (74.1) 6 (42.9) 
Weighing scales: Bathroom 
type 
7 (53.8) 15 (55.6) 8 (57.1) 
Weighing scales: Hospital 
type 
4 (30.8) 11 (40.7) 4 (28.6) 
Urine testing strips: 
Multiple test 
3 (23.1) 2 (7.4) 2 (14.3) 
Height meters 4 (30.8) 9 (33.3) 5 (35.7) 
Ophthalmoscope 3 (23.1) 12 (44.4) 6 (42.9) 
Snellen charts: Handheld 1 (7.7) 4 (14.8) 0 (0.0) 
Snellen charts: Distance 3 (23.1) 11 (40.7) 1 (7.1) 
BMI chart 4 (30.8) 5 (18.5) 1 (7.1) 
Other Equipment 
Tuning forks 1 (7.7) 4 (14.8) 2 (14.3) 
Monofilament 1 (7.7) 1 (3.7) 0 (0.0) 
Spirometer 1 (7.7) 0 (0.0) 0 (0.0) 
Spacers for inhalers 3 (23.1) 1 (3.7) 1 (7.1) 
Nebulizer 4 (30.8) 3 (11.1) 2 (14.3) 
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Speculum 7 (53.8) 17 (63.0) 9 (64.3) 
Bronchoscope 1 (7.7) 0 (0.0) 1 (7.1) 
Proctoscope 4 (30.8) 1 (3.7) 1 (7.1) 
Colonoscope 1 (7.7) 0 (0.0) 0 (0.0) 
Autoscope 6 (46.2) 6 (22.2) 6 (42.9) 
Emergency trolley/tray 4 (30.8) 14 (51.9) 3 (21.4) 




3 (23.1) 5 (18.5) 2 (14.3) 
Implemented equipment 
maintenance plan 
2 (15.4) 3 (11.1) 0 (0.0) 
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Ultrasound Scan 11 (84.6) 6 (54.6) 23 (85.2) 18 (78.3) 7 (50.0) 3 (42.9) 
Echography 3 (23.1) 1 (33.3) 1 (3.7) 1 (100.0) 0 (0.0) 0 (0.0) 
ECG Monitor 3 (23.1) 1 (33.3) 4 (14.8) 2 (50.0) 1 (7.2) 0 (0.0) 
X-Rays 10 (76.9) 6 (60.0) 22 (81.5) 12 (54.6) 2 (14.3) 0 (0.0) 
Doppler 5 (38.5) 3 (60.0) 1 (3.7) 0 (0.0) 0 (0.0) 0 (0.0) 
CT-Scan 2 (15.4) 1 (50.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Reliable power 
supply 
7 (53.9) 4 (57.1) 17 (63.0) 14 (82.4) 4 (28.6) 2 (50.0) 
Alternative source 
of power 












































Table 13. Availability of medicines and supplies by health facility type 
 
 

















last quarter  
N (%) 
Stockout 















     Thiazide diuretic  12 (92.3) 1 (7.7) 2 (15.4) 24 (88.9) 3 (11.1) 2 (7.4) 9 (64.3) 3 (21.4) 2 (14.3) 
     Calcium channel blocker 12 (92.3) 1 (7.7) 1  (7.7) 23 (85.2) 3 (11.1) 4 (14.8) 14 (100.0) 4 (28.6) 5 (35.7) 
     Beta-blocker 7 (53.8) 3 (23.1) 3 (23.1) 15 (55.6) 10 (37.0) 8 (29.6) 13 (92.9) 3 (21.4) 3 (21.4) 
     ACE inhibitor 10 (76.9) 2 (15.4) 2 (15.4) 21 (77.8) 5 (18.5) 6 (22.2) 6 (42.9) 2 (14.3) 2 (14.3) 
     Others (e.g. Methyldopa, 
hydralazine, magnesium sulphate) 
 
10 (76.9) 2 (15.4) 2 (15.4) 
 







Diabetic Drugs and Supplies  
     Biguanides 12 (92.3) 0 (0.0) 0 (0.0) 24 (88.9) 4 (14.8) 2 (7.4) 14 (100.0) 4 (28.6) 5 (35.7) 
     Sulfonylureas 11 (84.6) 2 (15.4) 2 (15.4) 22 (81.5) 6 (22.2) 2 (7.4) 11 (78.6) 3 (21.4) 4 (28.6) 
     Thiazolidinediones 1 (7.7) 2 (15.4) 2 (15.4) 2 (7.4) 5 (18.5) 4 (14.8) 1 (7.1) 1 (7.1) 1 (7.1) 
     Dipeptidyl peptidase-4 
inhibitors 
 1 (7.7) 1 (7.7) 1 (3.7) 5 (18.5) 4 (14.8)  1 (7.1)  1 (7.1) 0 (0.0) 
     Alpha-glucosidase inhibitors  1 (7.7) 1 (7.7) 2 (7.4) 5 (18.5) 5 (18.5) 0 (0.0) 0 (0.0) 1 (7.1) 
Ultra short-acting 8 (61.5) 1 (7.7) 0 (0.0) 10 (41.6) 3 (11.1) 6 (22.2) 3 (21.4) 0 (0.0) 0 (0.0) 
Short-acting 9 (69.2) 3 (23.1) 3 (23.1) 15 (55.6)  2 (7.4) 6 (22.2) 5 (35.7) 1 (7.1) 1 (7.1) 
Intermediate 10 (76.9) 3 (23.1) 5 (38.5) 13 (48.1) 4 (14.8) 6 (22.2) 3 (21.4) 0 (0.0) 0 (0.0) Insulin type 
Long-acting 11 (84.6) 3 (23.1) 4 (30.8) 15 (55.6) 4 (14.8) 5 (18.5) 3 (21.4) 1 (7.1) 1 (7.1) 
     Insulin syringes* 11 (84.6) 3 (23.1) 4 (30.8) 17 (63.0) 4 (14.8) 4 (14.8) 6 (42.9) 2 (14.3) 2 (14.3) 
Other drugs and supplies 
     Folic acid 12 (92.3) 2 (15.4) 2 (15.4) 25 (92.6) 2 (7.4) 4 (14.8) 14 (100.0) 3 (21.4) 4 (28.6) 
     Statins 2 (15.4) 4 (30.8) 3 (23.1) 2 (7.4) 4 (14.8) 5 (18.5) 3 (21.4) 1 (7.1) 1 (7.1) 
     Cardiac aspirin 11 (84.6) 4 (30.8) 4 (30.8) 16 (59.3) 5 (18.5) 6 (22.2) 5 (35.7) 5 (35.7) 5 (35.7) 
     Refrigerator* 12 (92.3)   19 (70.4)   3 (21.4)   
* These data are for the availability of the supplies in the pharmacy only, they do not account for the same type of supplies in other areas of the facilities. 
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Table 14. Laboratory equipment and test availability by health facility type 
 







On-site laboratory 13 (100%) 27 (100%) 12 (86%) 
Laboratory equipment 
Centrifuge 11 (84.6) 24 (88.9) 10 (71.4) 
Microscope 11 (84.6) 27 (100.0) 14 (100.0) 
Refrigerator 12 (92.3) 27 (100.0) 10 (71.4) 
General tests 
Hemoglobin 12 (92.3) 24 (88.9) 11 (78.6) 
Complete blood count and 
differential 
11 (84.6) 20 (74.1) 5 (35.7) 
Electrolytes 9 (69.2) 11 (40.7) 0 (0.0) 
Renal function 9 (69.2) 14 (51.9) 1 (7.1) 
Liver function 9 (69.2) 12 (44.4) 0 (0.0) 
Lipid profile 6 (46.2) 9 (33.3) 1 (7.1) 
Urinalysis 11 (84.6) 26 (96.3) 13 (92.9) 
Endocrine tests 
Random blood glucose 12 (92.3) 24 (88.9) 14 (100.0) 
Hemoglobin A1c 0 (0.0) 5 (18.5) 0 (0.0) 
Urine microalbumin 4 (30.8) 3 (11.1) 0 (0.0) 
Thyroid function 0 (0.0) 1 (3.7) 0 (0.0) 
Cancer tests 
Cytology 2 (15.4) 3 (11.1) 0 (0.0) 
Hemoccult 3 (23.1) 4 (14.8) 0 (0.0) 
Prostate-Specific Antigens 1 (7.7) 2 (7.4) 1 (7.1) 
Sickle cell disease tests 
Hemoglobin 
electrophoresis 
0 (0.0) 4 (14.8) 0 (0.0) 
Sickling test 11 (84.6) 21 (77.8) 7 (50.0) 
Infectious disease tests 
Bacteriology including 
culture and sensitivity 
5 (38.5) 6 (22.2) 0 (0.0) 
Thick Film 11 (84.6) 27 (100.0) 12 (85.7) 
Thin Film 11 (84.6) 24 (88.9) 11 (78.6) 
Other tests 
Blood grouping and cross-
match 
11 (84.6) 27 (100.0) 10 (71.4) 
Pregnancy test 9 (69.2) 24 (88.9) 14 (100.0) 
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Table 15. Description of individual health provider survey sample 
 
Cadre Number surveyed 
N (%) 
Nurse/Midwife 32 (27.6) 
Nursing Officer 18 (15.5) 
Clinical Officer 16 (13.8) 
Medical Officer 19 (16.4) 
Physician 10 (8.6) 
Other* 21 (18.1) 
* “Other” includes lab technicians, nursing assistants, hospital director, and missing. 
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Table 16. Confidence in NCD management by cadre  
 




















Hypertension       <0.001 
     Very confident 0 (0.0) 5 (27.8) 2 (12.5) 9 (47.4) 8 (80.0) 4 (22.2)  
     Confident 14 (43.8) 7 (38.9) 10 (62.5) 10 (52.6) 2 (20.0) 7 (38.9)  
     Somewhat 18 (56.3) 5 (27.8) 4 (25.0) 0 (0.0) 0 (0.0) 6 (33.3)  
     Not at all 0 (0.0) 1 (5.6) 0 (0.0) 0 (0.0) 0 (0.0) 1 (5.6)  
Diabetes       <0.001 
     Very confident 2 (6.3) 3 (16.7) 1 (6.3) 6 (31.6) 8 (80.0) 2 (11.1)  
     Confident 12 (37.5) 4 (22.2) 6 (37.5) 11 (57.9) 2 (20.0) 9 (50.0)  
     Somewhat 15 (46.9) 7 (38.9) 9 (56.3) 2 (10.5) 0 (0.0) 6 (33.3)  
     Not at all 3 (9.4) 4 (22.2) 0 (0.0) 0 (0.0) 0 (0.0) 1 (5.6)  
High cholesterol       <0.001 
     Very confident 0 (0.0) 0 (0.0) 0 (0.0) 2 (1.8) 6 (60.0) 0 (0.0)  
     Confident 4 (12.5) 3 (16.7) 1 (6.3) 5 (26.3) 4 (40.0) 4 (22.2)  
     Somewhat 5 (15.6) 4 (22.2) 3 (18.8) 6 (31.6) 0 (0.0) 6 (33.3)  
     Not at all 23 (71.9) 11 (61.1) 12 (75.0) 6 (31.6) 0 (0.0) 8 (44.4)  
Screening for cervical cancer       0.021 
     Very confident 3 (9.4) 0 (0.0) 0 (0.0) 4 (21.1) 3 (30.0) 3 (16.7)  
     Confident 4 (12.5) 1 (5.6) 0 (0.0) 4 (21.1) 3 (30.0) 2 (11.1)  
     Somewhat 3 (9.4) 5 (27.8) 6 (37.5) 6 (31.6) 1 (10.0) 2 (11.1)  
     Not at all 22 (68.8) 12 (66.7) 10 (62.5) 5 (26.3) 3 (30.0) 11 (61.1)  
Screening for breast cancer       0.037 
     Very confident 3 (9.4) 2 (11.1) 0 (0.0) 6 (31.6) 4 (40.0) 1 (5.6)  
     Confident 6 (18.8) 2 (11.1) 3 (18.8) 5 (26.3) 3 (30.0) 6 (33.3)  
     Somewhat 8 (25.0) 9 (50.0) 6 (37.5) 5 (26.3) 2 (20.0) 3 (16.7)  
     Not at all 15 (46.9) 5 (27.8) 7 (43.8) 3 (15.8) 1 (10.0) 8 (44.4)  
Diagnosis/management of asthma       <0.001 
     Very confident 5 (15.6) 0 (0.0) 6 (37.5) 12 (63.2) 7 (70.0) 9 (52.9)  
     Confident 16 (50.0) 13 (72.2) 8 (50.0) 6 (31.6) 3 (30.0) 2 (11.8)  
     Somewhat 7 (21.9) 4 (22.2) 2 (12.5) 1 (5.3) 0 (0.0) 4 (23.5)  
     Not at all 4 (12.5) 1 (5.6) 0 (0.0) 0 (0.0) 0 (0.0) 2 (11.8)  
Screening/management of 
depression & other mental health 
disorders 
    
  
0.049 
     Very confident 3 (9.4) 2 (11.1) 2 (11.1) 3 (15.8) 0 (0.0) 2 (11.1)  
     Confident 7 (21.9) 4 (22.2) 4 (22.2) 7 (36.8) 7 (77.8) 6 (33.3)  
     Somewhat 11 (34.4) 8 (44.4) 8 (50.0) 8 (42.1) 2 (22.2) 3 (16.7)  
     Not at all 11 (34.4) 4 (22.2) 1 (6.3) 1 (5.3) 0 (0.0) 7 (38.9)  
Screening/diagnosis/ 
management of sickle cell disease     
  <0.001 
     Very confident 1 (3.2) 0 (0.0) 0 (0.0) 6 (31.6) 5 (55.6) 3 (16.7)  
     Confident 2 (6.5) 5 (27.8) 6 (37.5) 11 (57.9) 4 (44.4) 5 (27.8)  
     Somewhat 15 (48.4) 8 (44.4) 6 (37.5) 2 (10.5) 0 (0.0) 6 (33.3)  
     Not at all 13 (41.9) 5 (27.8) 4 (25.0) 0 (0.0) 0 (0.0) 4 (22.2)  
Treatment of tobacco abuse       0.233 
     Very confident 2 (6.3) 2 (11.1) 1 (6.3) 2 (10.5) 0 (0.0) 1 (5.6)  
     Confident 9 (28.1) 3 (16.7) 2 (12.5) 2 (10.5) 5 (55.6) 4 (22.2)  
     Somewhat 6 (18.8) 7 (38.9) 5 (31.3) 8 (48.1) 4 (44.4) 3 (16.7)  
     Not at all 15 (46.9) 6 (33.3) 8 (50.0) 7 (36.8) 0 (0.0) 10 (55.6)  
Treatment of alcohol abuse       0.594 
     Very confident 2 (6.3) 2 (11.1) 1 (6.3) 2 (10.5) 1 (11.1) 0 (0.0)  
     Confident 15 (46.9) 7 (38.9) 3 (18.8) 4 (21.1) 4 (44.4) 6 (33.3)  
     Somewhat 6 (18.8) 5 (27.8) 7 (43.8) 7 (36.8) 4 (44.4) 5 (27.8)  
     Not at all 9 (28.1) 4 (22.2) 5 (31.3) 6 (31.6) 0 (0.0) 7 (38.9)  
        
† P-value is for χ2 test. 
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Table 17. Attitudes on NCD management by cadre 
 












There are effective depression treatments that can be provided by a primary care physician in my facility.                        0.363 
     Agree 6 (20.7) 2 (13.3) 4 (33.3) 4 (25.0) 0 (0.0) 1 (5.9)  
     Disagree 21 (72.4) 13 (86.7) 7 (58.3) 12 (75.0) 7 (100.0) 16 (94.1)  
     No opinion 2 (6.9) 0 (0.0) 1 (8.3) 0 (0.0) 0 (0.0) 0 (0.0)  
My clinical training prepared me adequately to manage chronic diseases.                                                                                0.075 
     Agree 19 (65.5) 12 (80.0) 3 (25.0) 10 (62.5) 7 (100.0) 11 (64.7)  
     Disagree 9 (31.0) 3 (20.0) 9 (75.0) 5 (31.3) 0 (0.0) 6 (35.3)  
     No opinion 1 (3.5) 0 (0.0) 0 (0.0) 1 (6.3) 0 (0.0) 0 (0.0)  
A doctor can influence whether a patient successfully quits smoking.                                                                                        0.335 
     Agree 22 (78.6) 7 (46.7) 9 (75.0) 7 (43.8) 5 (71.4) 13 (76.5) 
     Disagree 4 (14.3) 7 (46.7) 2 (16.7) 7 (43.8) 1 (14.3) 3 (17.7) 
     No opinion 2 (7.1) 1 (6.7) 1 (8.3) 2 (12.5) 1 (14.3) 1 (5.9) 
 
I am able to spend the time I need to provide good medical care for my patients with chronic diseases.                               0.315 
     Agree 24 (80.0) 10 (66.7) 5 (41.7) 9 (56.3) 5 (71.4) 13 (76.5) 
     Disagree 6 (20.0) 4 (26.7) 6 (50.0) 7 (43.8) 2 (28.6) 4 (23.5) 
     No opinion 0 (0.0) 1 (6.7) 1 (8.3) 0 (0.0) 0 (0.0) 0 (0.0) 
 
Patients receive better care for chronic medical conditions if they have a designated primary care provider.                     0.821 
     Agree 26 (86.7) 12 (80.0) 9 (75.0) 14 (87.5) 6 (85.7) 15 (88.2) 
     Disagree 2 (6.7) 3 (20.0) 2 (16.7) 2 (12.5) 1 (14.3) 2 (11.8) 
     No opinion 2 (6.7) 0 (0.0) 1 (8.3) 0 (0.0) 0 (0.0) 0 (0.0) 
 
My facility has the capacity to manage chronic diseases.                                                                                                             0.508 
     Agree 19 (63.3) 11 (73.3) 7 (63.6) 7 (43.8) 3 (42.9) 9 (56.3) 
     Disagree 10 (33.3) 4 (26.7) 3 (27.3) 7 (43.8) 2 (28.6) 6 (37.5) 
     No opinion 1 (3.3) 0 (0.0) 1 (9.1) 2 (12.5) 2 (28.6) 1 (6.3) 
 
† P-value is for χ2 test. 
 
 64 





No. of Regional 
Referral Hospitals 
that have resource 
(N=13) 
N (%) 
No. of General 




No. of HCIVs that 





Protocols for management 
and referral of NCD patients 
2 (15.4) 8 (29.6) 1 (7.1) 
Outgoing 11 (84.6) 23 (85.2) 8 (57.1) Referral form  
Receiving 6 (46.2) 7 (26.0) 4 (28.6) 
Transport to the next facility 7 (53.8) 10 (37.0) 7 (50.0) 
Outgoing 6 (46.2) 19 (70.4) 6 (42.9) Register to 
monitor follow-
up and gather 
statistics on 
referrals 
Receiving 4 (30.8) 15 (55.6) 5 (35.7) 
Program that integrates 
NCDs support supervision 
and capacity building in 
lower health facilities 
3 (23.1) 4 (14.8) 3 (21.4) 
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No. of Regional 
Referral Hospitals that 
do activity (N=13) 
 
N (%) 
No. of General 










Formal linkages to the 
community and regular 
meetings with 
community on NCDs 
1 (7.7) 6 (22.2) 1 (7.1) 
Communication  about 
disease states through 
media, gatherings, IEC, 
and/or village health 
teams 
6 (46.2) 11 (40.7) 3 (21.4) 
Partnerships with 
community 
organizations that focus 
on NCDs 
1 (7.7) 4 (14.8) 1 (7.1) 
Engagement with 
community in patient 
follow-up 




Table 20. Uganda Diabetic Association membership by health facility type 
 
No. of Regional Referral 
Hospitals (N=13) 
No. of General Hospitals 
(N=27) 
 


















Branch of Uganda 
Diabetic Association 
8 (61.5) 6 (75.0) 7 (26.0) 5 (71.4) 2 (14.3) 1 (50.0) 
* e.g. Regular meetings held, minutes available, work plans available, reports available and/or submitted to UDA 




Appendix A. List of health facilities surveyed 
 
Regional Referral Hospitals General Hospitals Health Center IVs 
Arua RRH Apac Hospital Serere HCIV 
Fort Portal RRH Mityana Hospital Kabwohe HCIV 
Gulu RRH Kaabong Hospital Nabilatuk HCIV 
Hoima RRH Tororo Hospital Rwekubo HCIV 
Jinja RRH Anaka Hospital Amuria HCIV 
Kabale RRH Kamuli Hospital Kamukira HCIV 
Lira RRH Kisoro Hospital Sembabule HCIV 
Masaka RRH Lyantonde Hospital Koboko HCIV 
Mbale RRH Bundibugyo Hospital Padibe HCIV 
Mbarara RRH Itojo Hospital Dokolo HCIV 
Moroto RRH Rakai Hospital Budaka HCIV 
Mubende RRH Kyenjojo Hospital Alebtong HCIV 
Soroti RRH Abim Hospital Kebisoni HCIV 
 Kagadi Hospital  
 Bwera Hospital  
 Moyo Hospital  
 Iganga Hospital  
 Rushere Hospital  
 Pallisa Hospital  
 Nebbi Hospital  
 Atutur Hospital  
 Masindi Hospital  
 Kiboga Hospital  
 Kiryandongo Hospital  
 Kitgum Hospital  
 Bugiri Hospital  




Appendix B. Uganda Ministry of Health Noncommunicable Diseases needs assessment 
survey 
 




Non-­‐Communicable	  Diseases	  Needs	  Assessment	  Tool	  
	  







Background:	  Non-­‐communicable	  diseases	  (NCDs)	  are	  currently	  the	  leading	  killer	  diseases	  globally,	  and	  are	  on	  the	  
rise.	  About	  80%	  of	  NCDs	  deaths	  occur	  in	  low	  and	  middle-­‐income	  countries,	  including	  Uganda.	  The	  major	  NCDs	  in	  
Uganda	  are	  diabetes	  mellitus,	  hypertension,	  cardiovascular	  disease,	  and	  some	  cancers,	  while	  others	  include	  renal	  
disease,	  sickle	  cell	  disease,	  and	  chronic	  obstructive	  pulmonary	  disease	  (COPD).	  Among	  the	  challenges	  of	  NCD	  
control	  in	  Uganda	  are	  the	  lack	  of	  baseline	  data	  on	  prevalence	  and	  risk	  factors,	  and	  the	  inadequate	  capacity	  of	  the	  
existing	  health	  system	  to	  provide	  quality	  NCDs	  services.	  	  
The	  Uganda	  Ministry	  of	  Health	  (MoH)	  prioritizes	  NCDs	  especially	  in	  regard	  to	  prevention,	  early	  diagnosis,	  and	  
proper	  management.	  In	  partnership	  with	  the	  World	  Diabetic	  Foundation	  (WDF),	  the	  MoH	  has	  embarked	  on	  a	  
countrywide	  program	  to	  build	  capacity	  in	  the	  control	  and	  clinical	  management	  of	  NCDs	  (with	  emphasis	  on	  
diabetes)	  at	  the	  different	  levels	  of	  health	  care.	  A	  Needs	  Assessment	  is	  therefore	  essential	  to	  identify	  the	  existing	  
gaps	  and	  plan	  appropriate	  interventions.	  
	  
Purpose:	  To	  assess	  the	  capacity	  of	  Health	  Facilities	  to	  detect	  and	  manage	  NCDs,	  as	  well	  as	  identify	  areas	  for	  
improvement.	  	  
	  
Overview:	  There	  are	  13	  main	  sections	  of	  the	  tool.	  	  
They	  include:	  (A)	  Visit	  Information,	  (B)	  Health	  Facility	  Profile,	  (C)	  Human	  Resource	  and	  Skills	  Profile,	  (D)	  Facility-­‐
Based	  NCD	  Prevalence,	  (E)	  Clinics	  and	  Services,	  (F)	  Equipment,	  (G)	  Medicines	  &	  Sundries,	  (H)	  Laboratory,	  (I)	  Costs	  
Related	  to	  NCDs,	  (J)	  Referral	  System,	  (K)	  Health	  Care	  Providers’	  Skills	  and	  Attitudes,	  (L)	  Community	  Involvement	  
(Engagement),	  and	  (M)	  Associations/Patient	  Groups.	  	  
	  
Instructions:	  	  	  
- For	  a	  Yes/No	  question	  (e.g.	  “Is	  there	  a	  pharmacy	  in	  your	  facility?”),	  please	  mark	  “YES”	  as	  “Y”	  and	  “NO”	  as	  
“N”	  in	  the	  box	  provided.	  	  
- If	  the	  question	  asks	  for	  the	  “Number”	  (e.g.	  “How	  many	  weighing	  scales	  are	  there?”),	  please	  simply	  write	  
the	  number	  of	  items	  in	  the	  appropriate	  box.	  
- Other	  questions	  will	  show	  the	  numbers	  that	  correspond	  to	  specific	  answers.	  
- If	  the	  question	  does	  not	  apply,	  please	  write	  “not	  applicable”	  or	  “N/A”.	  
	  
Abbreviations:	  
- NCD:	  Non-­‐Communicable	  Disease	  
- DM:	  Diabetes	  Mellitus	  
- HT:	  Hypertension	  
- COPD:	  Chronic	  Obstructive	  Pulmonary	  Disease	  
- Cardio:	  Cardiology	  
- SC:	  Sickle	  Cell	  
- OB/GY:	  Obstetrics/Gynecology	  
- MOPD:	  Medical	  Outpatient	  Department	  
- IEC:	  Information	  Education	  Communication	  
- CME:	  Continuing	  Medical	  Education	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A.	  VISIT	  INFORMATION	  
	   	   	  
A1	   Date	  of	  visit	  (dd/mm/yy)	   	  
1)	  
2)	  




Title/Qualification	   	  
NCD	  involvement	   	  
1	  
Contact	   	  
	  
Name	   	  
Title/Qualification	   	   	  
NCD	  involvement	   	  
2	  
Contact	   	  
	  
Name	   	  
Title/Qualification	   	   	  
NCD	  involvement	   	  
3	  
Contact	   	  
	  
Name	   	  
Title/Qualification	   	  
NCD	  involvement	   	  
A3	  
4	  
Contact	   	  
	  
	  
B.	  HEALTH	  FACILITY	  PROFILE	  
	  
B1	   Name	  of	  health	  facility	   	  
B2	   City/town	   	  









	  	  	  	  	  
	  	  	  	  	  
Public	  
	  	  	  	  	  Private	  
	  	  	  	  
	  	  	  	  
B5	   Health	  facility	  category:	  
National	  Referral	  Hospital	  –	  1;	  Regional	  Referral	  Hospital	  –	  2;	  	  
General	  Hospital	  –	  3;	  Health	  Centre	  IV	  –	  4	  
	  
	  
                                                
1	  Personnel	  interviewed	  should	  be	  from	  any	  of	  the	  following	  areas:	  Administration,	  Pharmacy,	  Clinicians	  in	  NCD	  clinics	  
(including	  nurses),	  Records,	  and/or	  Laboratory. 
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C.	  HUMAN	  RESOURCE	  AND	  SKILLS	  PROFILE	  
	  
Are	  the	  following	  personnel	  in	  the	  facility,	  and	  if	  so,	  how	  many	  of	  each	  specialty/position?	  
	   Specialty/Position	   Yes/No	   Number	   Additional	  Skills2	  	  
C1	   Cardiologist	   	   	   	  
C2	   Clinical	  Officer(s)	   	   	   	  
C3	   Community	  Health	  Worker(s)	   	   	   	  
C4	   (NCDs)	  Counsellors	   	   	   	  
C5	   Endocrinologist/Diabetologist	  	   	   	   	  
C6	   Family	  physician	   	   	   	  
C7	   Foot	  care	  specialist	   	   	   	  
C8	   General	  surgeon	   	   	   	  
C9	   Laboratory	  technician(s)	   	   	   	  
C10	   Laboratory	  technologist(s)	   	   	   	  
C11	   Medical	  Officer(s)	   	   	   	  
C12	   Medical	  social	  workers	   	   	   	  
C13	   Midwives	   	   	   	  
C14	   NCD	  (DM)	  Educator	   	   	   	  
C15	   Neurologist	   	   	   	  
C16	   Nurse(s)	  –	  general	   	   	   	  
C17	   Nurse(s)	  –	  diabetic	  	   	   	   	  
C18	   Nurse(s)	  –	  psychiatric	  	   	   	   	  
C19	   Nutritionist(s)	   	   	   	  
C20	   Obstetrician/Gynecologist	   	   	   	  
C21	   Oncologist	   	   	   	  
C22	   Ophthalmologist	  	   	   	   	  
C23	   Paediatrician	   	   	   	  
C24	   Pathologist	   	   	   	  
C25	   Physiotherapist	   	   	   	  
C26	   Psychiatrist	   	   	   	  
C27	   Pulmonologist	  (or	  Chest	  physician)	   	   	   	  
C28	   Radiologist(s)	   	   	   	  
C29	   Radiology	  technician(s)	   	   	   	  
C30	   Specialist	  Physician	  	   	   	   	  
C31	   Vascular	  Surgeon	  	   	   	   	  












                                                
2	  e.g.	  Foot	  care,	  palliative	  care,	  nutrition,	  cancer	  screening,	  sickle	  cell	  screening,	  mental	  health	  skills,	  and	  any	  other	  skill.	  Please	  
list	  skill	  and	  then	  number	  of	  personnel	  with	  the	  specified	  skill.	  For	  example:	  Foot	  care	  (2).	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D.	  FACILITY-­‐BASED	  NCDs	  PREVALENCE	  
	  
	   NUMBER	  OF	  CASES	  IN	  LAST	  FINANCIAL	  YEAR3	   NUMBER	  
D1	   Estimated	  number	  of	  overall	  patients	  in	  your	  facility4	   	  
D2	   Estimated	  number	  of	  patients	  with	  NCDs	  	   	  
D3	   Total	  number	  of	  diabetes	  cases	   	  
D4	   	  	  	  	  Adults	   	  
D5	   	  	  	  	  Children	   	  
D6	   	  	  	  	  Pregnant	  women	   	  
D7	   Total	  number	  of	  hypertension	  cases	   	  
D8	   	  	  	  	  Pregnant	  women	   	  
D9	   Total	  number	  of	  cancer	  cases	   	  
	  D10	   	  	  	  	  Breast	  cancer	   	  
D11	   	  	  	  	  Cervix	  cancer	   	  
D12	   	  	  	  	  Prostate	  cancer	   	  
D13	   	  	  	  	  Lung	  cancer	   	  
D14	   	  	  	  	  Liver	  cancer	   	  
	   	  	  	  	  Kaposi’s	  sarcoma	   	  
	   	  
	   	  
D15	   	  	  	  	  Other	  cancer	  	  
(specify)	  
	   	  
D16	   Total	  number	  of	  heart	  disease	  cases	   	  
D17	   	  	  	  	  Adults	   	  
D18	   	  	  	  	  Children	   	  
D19	   Total	  number	  of	  asthma	  cases	   	  
D20	   Total	  number	  of	  other	  COPD	  cases5	   	  
D21	   Total	  number	  of	  stroke	  cases	   	  
D22	   Total	  number	  of	  renal	  disease	  cases	   	  
D23	   Total	  number	  of	  mental	  health	  disorder	  cases	   	  
D24	   Total	  number	  of	  sickle	  cell	  disease	  cases	   	  
D25	   Total	  number	  of	  injury	  cases	  –	  road	  traffic	  accidents	   	  
D26	   Total	  number	  of	  injury	  cases	  –	  gender-­‐based	  violence	   	  
D27	   Total	  number	  of	  injury	  cases	  –	  trauma	  due	  to	  other	  causes	   	  
D28	   Total	  number	  of	  alcohol-­‐related	  cases	   	  












                                                
3 Please	  obtain	  actual	  number	  of	  patients	  from	  register. 
4	  Both	  inpatient	  (admission)	  and	  outpatient.	  
5	  COPD	  –	  defined	  as	  progressive	  symptoms	  of	  cough,	  and/or	  sputum	  production,	  and/or	  dyspnea	  for	  more	  than	  3	  months	  
where	  asthma	  and	  infectious	  causes	  have	  been	  excluded. 
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E.	  CLINICS	  AND	  SERVICES	  
Clinics	  
	   DM	   HT	   Cancer	   Cardio	   COPD	   Renal	   SC	   OB/GY	   Paed	   HIV	   Surgery	   MOPD	  
E1	   Do	  you	  have	  a	  clinic	  (NCD)?	  (Y/N)	   	   	   	   	   	   	   	   	   	   	   	   	  
E2	   Do	  you	  have	  a	  separate	  (NCD)	  clinic	  
room?	  (Y/N)	  
	   	   	   	   	   	   	   	   	   	   	   	  
E3	   How	  often	  is	  the	  clinic	  held?	   	   	   	   	   	   	   	   	   	   	   	   	  
E4	   When	  is	  the	  clinic	  held?	   	   	   	   	   	   	   	   	   	   	   	   	  
E5	   Is	  there	  regular	  patient	  review?	  (Y/N)	   	   	   	   	   	   	   	   	   	   	   	   	  
E6	   If	  yes,	  how	  often	  is	  each	  patient	  
reviewed?	  
	   	   	   	   	   	   	   	   	   	   	   	  
E7	   Does	  the	  clinic	  conduct	  performance	  
audits?	  (Y/N)	  
	   	   	   	   	   	   	   	   	   	   	   	  
E8	   If	  yes,	  specify.6	   	   	   	   	   	   	   	   	   	   	   	   	  
 
Services	  
	   	   DM	   HT	   Cancer	   Cardio	   COPD	   Renal	   SC	   OB/GY	   Paed	   HIV	   Surgery	   MOPD	  
	   Are	  the	  following	  services	  offered?	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	  
E9	   Blood	  Pressure	  measurement	   	   	   	   	   	   	   	   	   	   	   	   	  
E10	   Weight	   	   	   	   	   	   	   	   	   	   	   	   	  
E11	   Height	  	   	   	   	   	   	   	   	   	   	   	   	   	  
E12	   BMI	  calculation	   	   	   	   	   	   	   	   	   	   	   	   	  
E13	   Waist:Hip	  ratio	   	   	   	   	   	   	   	   	   	   	   	   	  
E14	   Blood	  glucose	   	   	   	   	   	   	   	   	   	   	   	   	  
E15	   Oral	  Glucose	  Tolerance	  Test	  (OGTT)	   	   	   	   	   	   	   	   	   	   	   	   	  
E16	   Blood	  lipids	   	   	   	   	   	   	   	   	   	   	   	   	  
E17	   Urinalysis	   	   	   	   	   	   	   	   	   	   	   	   	  
E18	   Urine	  protein	   	   	   	   	   	   	   	   	   	   	   	   	  
E19	   Urine	  ketones	  	   	   	   	   	   	   	   	   	   	   	   	   	  
E20	   Eye	  examination	   	   	   	   	   	   	   	   	   	   	   	   	  
E21	   Individual	  patient	  NCD	  education	   	   	   	   	   	   	   	   	   	   	   	   	  
E22	   Group	  NCD	  education	   	   	   	   	   	   	   	   	   	   	   	   	  
E23	   Foot	  care	  for	  Diabetic	  patients	   	   	   	   	   	   	   	   	   	   	   	   	  
E24	   Nutrition	  advice	  for	  all	  patients	   	   	   	   	   	   	   	   	   	   	   	   	  
E25	   Sickle	  cell	  screening	  (incl.	  newborns)	   	   	   	   	   	   	   	   	   	   	   	   	  
                                                
6	  e.g.	  loss	  to	  follow-­‐up,	  deaths,	  availability	  of	  drugs,	  etc.	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E26	   Cervical	  cancer	  screening	  (pap	  
smear)	  
	   	   	   	   	   	   	   	   	   	   	   	  
E27	   Breast	  cancer	  screening	   	   	   	   	   	   	   	   	   	   	   	   	  
E28	   Prostate	  cancer	  screening	   	   	   	   	   	   	   	   	   	   	   	   	  
E29	   Cytology/pathology	  services	   	   	   	   	   	   	   	   	   	   	   	   	  
E30	   Palliative	  care	   	   	   	   	   	   	   	   	   	   	   	   	  
E31	   Chemotherapy	   	   	   	   	   	   	   	   	   	   	   	   	  
E32	   Radiotherapy	   	   	   	   	   	   	   	   	   	   	   	   	  
E33	   Physiotherapy	   	   	   	   	   	   	   	   	   	   	   	   	  
E34	   Record	  of	  family	  history	  of	  NCDs	   	   	   	   	   	   	   	   	   	   	   	   	  
E35	   NCD	  patient	  card	   	   	   	   	   	   	   	   	   	   	   	   	  
E36	   Provision	  of	  NCDs	  IEC	  materials	   	   	   	   	   	   	   	   	   	   	   	   	  





E38	   Patient	  treatment	  plans	   	   	   	   	   	   	   	   	   	   	   	  
E39	   Self-­‐management	  support8 	   	   	   	   	   	   	   	   	   	   	   	  
E40	   Peer/social	  support	  linkage9	   	   	   	   	   	   	   	   	   	   	   	  
Guidelines	  
	   	   DM	  
	  
HT	   Cancer	   Cardio	   COPD	   Renal	   SC	   OB/GY	   Paed	   HIV	   Surg	   MOPD	  
	   Are	  the	  following	  guidelines	  used?	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	  
E41	   Diabetes	  management	   	   	   	   	   	   	   	   	   	   	   	   	  
E42	   Hypertension	  management	  	   	   	   	   	   	   	   	   	   	   	   	   	  
E43	   Hyperlipidemia	  management	   	   	   	   	   	   	   	   	   	   	   	   	  
E44	   Tobacco	  screening	  &	  treatment	   	   	   	   	   	   	   	   	   	   	   	   	  
E45	   Alcohol	  screening	  &	  treatment	   	   	   	   	   	   	   	   	   	   	   	   	  
E46	   Cancer	  (cervical,	  breast,	  prostate)	  
screening	  &	  treatment	  
	   	   	   	   	   	   	   	   	   	   	   	  
E47	   Mental	  health	  screening	  &	  
treatment	  
	   	   	   	   	   	   	   	   	   	   	   	  
E48	   Asthma	  management	   	   	   	   	   	   	   	   	   	   	   	   	  
E49	   Sickle	  cell	  screening	  &	  management	   	   	   	   	   	   	   	   	   	   	   	   	  
E50	   Palliative	  care	   	   	   	   	   	   	   	   	   	   	   	   	  
COMMENTS:	  (include	  type	  of	  guidelines	  used,	  e.g.	  WHO,	  UCG	  –	  Uganda	  Clinical	  Guidelines	  or	  IDF	  –	  International	  Diabetic	  Federation).	  Also	  mention	  about	  any	  Rehabilitation	  services.	  
	  
	  
                                                
7	  Brochures,	  booklets,	  magazines,	  CDs,	  dummies,	  posters,	  audiotapes,	  etc.	  
8	  e.g.	  Lifestyle	  modification	  











Number	  of	  known	  HIV	  patients	  
E39	   Total	  number	  of	  active	  patients	  with	  HIV	  in	  the	  last	  





E40	   Number	  of	  new	  cases	  in	  last	  3	  financial	  years	  
2010-­‐11:	  
E41	   Number	  of	  active	  HIV	  patients	  with	  cancer	   	  
E42	   Number	  of	  active	  HIV	  patients	  with	  diabetes	   	  
E43	   Number	  of	  active	  HIV	  patients	  with	  hypertension	   	  
E44	   Number	  of	  active	  HIV	  patients	  with	  CVD	   	  
E45	   Number	  of	  active	  HIV	  patients	  with	  liver	  disease	   	  













                                                
10	  An	  “active	  patient”	  has	  attended	  the	  HIV	  clinic	  within	  the	  last	  6	  months.	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   DM	   HT	   Cancer	   Cardio	   COPD	   Renal	   SC	   OB/GY	   Paed	   HIV	   Surgery	   MOPD	  
Is	  the	  following	  equipment	  available	  in	  the	  


























F1	   Clinicians	  table	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F2	   Nurses	  station/table	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F3	   Hand	  washing	  basin/sink	  with	  soap	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F4	   Patient	  files	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F5	   File	  cabinet/cupboard/storage	  space	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F6	   NCD	  register:	  for	  new	  cases	  only	   	   	   	   	   	   	   	   	   	   	   	   	  
F7	   NCD	  register:	  for	  follow-­‐up	  cases	  only	   	   	   	   	   	   	   	   	   	   	   	   	  
F8	   NCD	  register:	  for	  admission	  only	   	   	   	   	   	   	   	   	   	   	   	   	  
F9	   Number	  present	   	   	   	   	   	   	   	   	   	   	   	   	  





ometer	  	   #	  Calibrated	   	   	   	   	   	   	   	   	   	   	   	   	  
F12	   Number	  present	   	   	   	   	   	   	   	   	   	   	   	   	  




#	  Calibrated	   	   	   	   	   	   	   	   	   	   	   	   	  
F15	   Number	  present	   	   	   	   	   	   	   	   	   	   	   	   	  




#	  Calibrated	  	   	   	   	   	   	   	   	   	   	   	   	   	  
F18	   BP	  cuffs:	  Standard	  (25	  cm	  x	  12	  cm)	   	   	   	   	   	   	   	   	   	   	   	   	  
F19	   BP	  cuffs:	  Alternate	  (36	  cm	  x	  12	  cm)	   	   	   	   	   	   	   	   	   	   	   	   	  
F20	   BP	  cuffs:	  Paediatric	   	   	   	   	   	   	   	   	   	   	   	   	  





Number	  functional	   	   	   	   	   	   	   	   	   	   	   	   	  
F23	   Number	  present	   	   	   	   	   	   	   	   	   	   	   	   	  
F24	   Number	  functional	   	   	   	   	   	   	   	   	   	   	   	   	  





Cost	  of	  strips	  per	  unit	   	   	   	   	   	   	   	   	   	   	   	   	  
F27	   Urine	  testing	   Multiple	  test	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F29	   strips	   Availability?	  Always	  –	  
1;	  Sometimes	  –	  2;	  
Never	  –	  0	  
	   	   	   	   	   	   	   	   	   	   	   	  
F30	   #	  Bathroom	  type	  	   	   	   	   	   	   	   	   	   	   	   	   	  
F31	  
Weighing	  
scales	  	   #	  Hospital	  type	  	   	   	   	   	   	   	   	   	   	   	   	   	  
F32	   Number	  present	   	   	   	   	   	   	   	   	   	   	   	   	  
F33	  
Height	  meters	  	  
#	  Calibrated	  correctly	   	   	   	   	   	   	   	   	   	   	   	   	  
F34	   Number	  present	   	   	   	   	   	   	   	   	   	   	   	   	  
F35	  
Ophthalmo-­‐
scope	   Number	  functional	   	   	   	   	   	   	   	   	   	   	   	   	  





#	  Distance	  type	   	   	   	   	   	   	   	   	   	   	   	   	  
	   DM	   HT	   Cancer	   Cardio	   COPD	   Renal	   SC	   OB/GY	   Paed	   HIV	   Surgery	   MOPD	  

























F38	   BMI	  chart	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F39	   Measuring	  tapes	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F40	   Tuning	  forks	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F41	   Monofilament	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F42	   Spirometer	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F43	   Spacers	  for	  inhalers	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F44	   Nebuliser	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F45	   Thermometers	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F46	   Speculum	  (cervix)	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F47	   Bronchoscope	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F48	   Proctoscope	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F49	   Colonoscope	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F50	   Autoscope	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F51	   Emergency	  Trolley/Tray11	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F52	   Physiotherapy	  equipment	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
F53	   Other	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
                                                
11	  Please	  specify	  under	  comments	  what	  your	  emergency	  trolley/tray	  contains.	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   (Specify)	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	  
	   Maintenance	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	   Y/N	  
F54	   Is	  there	  a	  written	  equipment	  
maintenance	  plan?	  
	   	   	   	   	   	   	   	   	   	   	   	  
F55	   If	  yes,	  is	  the	  plan	  implemented?	   	   	   	   	   	   	   	   	   	   	   	   	  
	   Imaging	   Available?	   Functional?	  
F56	   Ultrasound	  scan	   	   	  
F57	   Echography	   	   	  
F58	   ECG	  monitor	   	   	  
F59	   X-­‐Rays	   	   	  
F60	   Doppler	   	   	  
F61	   CT-­‐Scan	   	   	  
F62	   Other,	  specify	   	   	  
	   Power	  Supply	   Available?	   Functional?	  
F63	   Reliable	  power	  supply	   	   	  














                                                
12	  e.g.	  standby	  generator,	  solar,	  etc. 
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G.	  MEDICINES	  AND	  SUNDRIES	  
G1	   Is	  there	  a	  drug	  store	  (pharmacy)	  in	  your	  facility?	  (Y/N)	   	  
Medicines	  
How	  often	  are	  they	  
stocked?	  	  
	   	  
	  
















Was	  there	  a	  stock-­‐
out	  in	  the	  last	  
financial	  year?	  
	   Anti-­‐hypertensives	   	   	   	   	  
G2	   Thiazide	  diuretic	  (e.g.	  Aprinox)	   	   	   	   	  
G3	   Calcium	  channel	  blocker	  (e.g.	  Nifedipine)	   	   	   	   	  
G4	   Beta-­‐blocker	  (e.g.	  Propranolol)	   	   	   	   	  
G5	   ACE	  inhibitor	  (e.g.	  Captopril)	   	   	   	   	  
G6	   Others	  (e.g.	  Aldomet,	  Hydrallazine,	  
Magnesium	  Sulphate)	  
	   	   	   	  
	   Diabetic	  drugs	   	   	   	   	  
G7	   Biguanides	  	  (e.g.	  Metformin)	   	   	   	   	  
G8	   Sulfonylureas	  (e.g.	  Glibenclamide)	   	   	   	   	  
G9	   Thiazolidinediones	  (e.g.	  Pioglitazone)	   	   	   	   	  
G10	   Dipeptidyl	  peptidase-­‐4	  inhibitors	   	   	   	   	  
G11	   Alpha-­‐glucosidase	  inhibitors	   	   	   	   	  
G12	   Others	   	   	   	   	  
G13	   Ultra	  short-­‐acting	  	   	   	   	   	  
G14	   Short-­‐acting	  	   	   	   	   	  
G15	   Intermediate	  	   	   	   	   	  
G16	  
Insulin	  type	  available	  
Long-­‐acting	  	   	   	   	   	  
U	  100	   	   	   	   	  G17	   Strength	  of	  insulin	  
available	   Other	   	   	   	   	  
G18	   Insulin	  syringes	  (e.g.	  U100)	   	   	   	   	  
	   For	  other	  diseases	   	   	   	   	  
G19	   Folic	  acid	   	   	   	   	  
G20	   Statins	   	   	   	   	  
G21	   Cardiac	  Aspirin	   	   	   	   	  
G22	   Sulfadoxine/pyrimethamine	  (e.g.	  Fansidar)	   	   	   	   	  
G23	   Antibiotics,	  specify:	   	   	   	   	  
G24	   Anticoagulants	   	   	   	   	  
G25	   Anticancer,	  specify:	   	   	   	   	  
G26	   Other13	   	   	   	   	  
Other	  Questions	  
	   What	  is	  the	  source	  of	  procurement?	  	  
G27	   Government	   	  
                                                
13	  Include	  renal,	  and	  other	  drugs.	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G28	   Other,	  and	  specify14	  	   	  
G29	   Do	  you	  get	  the	  types	  of	  drugs	  you	  ask	  for?	   	  
G30	   Do	  you	  get	  the	  quantity	  of	  drugs	  you	  ask	  for?	   	  







































                                                











	   QUESTION	   YES/NO	  
H1	   Is	  there	  a	  laboratory	  in	  the	  facility?	   	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Are	  the	  following	  lab	  tests	  done?	  
H2	   	  	  	  	  Bacteriology	  including	  culture	  and	  sensitivity	   	  
H3	   	  	  	  	  Blood	  Grouping	  and	  Cross-­‐match	  	   	  
H4	   	  	  	  	  Cytology	   	  
H5	   	  	  	  	  Electrolytes	  (e.g.,	  potassium)	   	  
H6	   	  	  	  	  Full	  blood	  count	  and	  differential	   	  
H7	   	  	  	  	  Full	  Urinalysis	   	  
H8	   	  	  	  	  Hb	  electrophoresis	   	  
H9	   	  	  	  	  HbA1c	   	  
H10	   	  	  	  	  Hemoccult	   	  
H11	   	  	  	  	  Hemoglobin	  	   	  
H12	   	  	  	  	  Hormonal	  Assays	  (other)	   	  
H13	   	  	  	  	  Lipid	  Profile	   	  
H14	   	  	  	  	  Liver	  Function	  Tests	   	  
H15	   	  	  	  	  Microalbuminuria	   	  
H16	   	  	  	  	  Pregnancy	  test	   	  
H17	   	  	  	  	  PSA	   	  
H18	   	  	  	  	  Random	  Blood	  Sugar	   	  
H19	   	  	  	  	  Renal	  Function	  Tests	   	  
H20	   	  	  	  	  Sickling	  test	   	  
H21	   	  	  	  	  Thick	  Film	   	  
H22	   	  	  	  	  Thin	  Film	   	  
H23	   	  	  	  	  Thyroid	  function	  tests	   	  
H24	   	  	  	  	  Other,	  specify15	   	  
H25	   Is	  there	  a	  functional	  centrifuge	  available?	   	  
H26	   Is	  there	  a	  functional	  microscope	  available?	   	  
H27	   Is	  there	  a	  functional	  refrigerator	  available?	   	  
                                                
















K. COSTS	  RELATED	  TO	  NCDS16	  
	  
	   GENERAL	  ITEM	   SPECIFY	  ITEM	   COST	  ESTIMATE17	  
	   	  I1	   Drugs	  
	   	  
	   	  I2	   Labs	  
	   	  
	   	  I3	   Imaging	  
	   	  
	   	  I4	   Other	  Services	  











J.	  REFERRAL	  SYSTEM	  
	  
	   QUESTION	   YES/NO	  
J1	   Health	  System:	  Availability	  of	  protocols	  for	  management	  and	  referral	  of	  NCD	  patients	  




J2	   If	  yes	  specify:	  
	  
Outgoing	   	  J3	   Health	  System:	  Availability	  of	  a	  referral	  form	  (or	  any	  other	  form	  of	  
communication)	  to	  the	  next	  facility	  	   Receiving	  	   	  
J4	   Health	  System:	  Availability	  of	  transport	  to	  the	  next	  facility	   	  
Outgoing	   	  J5	   Referral	  Practicalities:	  A	  register	  exists	  to	  monitor	  follow-­‐up	  and	  
gather	  statistics	  on	  referrals	  	   Receiving	   	  
J6	   Supervision	  and	  Capacity	  Building:	  The	  facility	  has	  a	  program	  that	  integrates	  NCDs	  








                                                
16	  Costs	  for	  patients	  related	  to	  NCDs.	  







K.	  HEALTH	  CARE	  PROVIDERS’	  SKILLS	  AND	  ATTITUDES	  
	  
ACCESS	  
	   Do	  you	  have	  access	  to	  the	  following	  resources?	   Yes/No	  
K1	   	  	  	  Facility-­‐specific	  NCD	  guidelines	   	  
K2	   	  	  	  National/WHO	  NCD	  guidelines	  	   	  
K3	   	  	  	  NCD	  journal	  articles	   	  
K4	   Do	  you	  receive	  “medical	  alerts”18	  on	  NCD	  patients?	   	  
K5	   Do	  you	  receive	  NCD	  support	  supervision?	   	  
	   SKILLS	  (target	  NCDs	  team)	  
	   Phys.	   MOs	   Cos	   Nurse	   Other	  
K6	   How	  many	  have	  received	  any	  special	  training	  or	  CME	  on	  NCDs?	   	   	   	   	   	  
	   How	  many	  have	  received	  training	  or	  CME	  in	  the	  following	  areas?	  
K7	   	  	  	  Prevention/management	  of	  hypertension	   	   	   	   	   	  
K8	   Prevention/management	  of	  diabetes	   	   	   	   	   	  
K9	   Prevention/management	  of	  heart	  disease	   	   	   	   	   	  
K10	   Screening	  breast	  cancer	   	   	   	   	   	  
K11	   Screening	  cervical	  cancer	   	   	   	   	   	  
K12	   Diagnosis/management	  of	  asthma	   	   	   	   	   	  
K13	   Diagnosis/management	  of	  COPD	   	   	   	   	   	  
K14	   Screening/diagnosis/management	  of	  sickle	  cell	  disease	   	   	   	   	   	  
K15	   Screening/diagnosis/management	  of	  depression	  &	  mental	  health	  
d/o	  
	   	   	   	   	  
K16	   Screening/management	  tobacco	  abuse	   	   	   	   	   	  
K17	   Screening/management	  alcohol	  abuse	   	   	   	   	   	  















                                                




Individual	  Provider	  Survey	  
 
K18	   Cadre:	   	  
K19	   Clinic:	   	  
	   CONFIDENCE	  IN	  NCD	  MANAGEMENT	   	  
	   Not	  at	  all	  –	  1;	  Somewhat	  –	  2;	  Confident	  –	  3;	  Very	  confident	  -­‐	  4	   Response	  
	  K20	   	  	  	  Hypertension	   	  
K21	   	  	  	  Diabetes	  	   	  
K22	   	  	  	  High	  cholesterol	   	  
K23	   	  	  	  Screening	  for	  cervical	  cancer	   	  
K24	   	  	  	  Screening	  for	  breast	  cancer	   	  
K25	   	  	  	  Diagnosis/management	  of	  asthma	   	  
K26	   	  	  	  Screening/management	  of	  depression	  &	  other	  mental	  health	  disorders	   	  
K27	   	  	  	  Screening/diagnosis/management	  of	  sickle	  cell	  disease	   	  
K28	   	  	  	  Treatment	  of	  tobacco	  abuse	   	  
K29	   	  	  	  Treatment	  of	  alcohol	  abuse	   	  
ATTITUDES	  
	   Agree	  –	  1;	  Disagree	  –	  2;	  No	  opinion	  –	  3	  	   Response	  
K30	   There	  are	  no	  effective	  depression	  treatments	  that	  can	  be	  provided	  by	  a	  primary	  
care	  physician	  in	  my	  facility.	  
	  
K31	   My	  clinical	  training	  prepared	  me	  adequately	  to	  manage	  chronic	  diseases.	   	  
K32	   A	  doctor	  can	  influence	  whether	  a	  patient	  successfully	  quits	  smoking.	   	  
K33	   I	  am	  able	  to	  spend	  the	  time	  I	  need	  to	  provide	  good	  medical	  care	  for	  my	  patients	  
with	  chronic	  diseases.	  
	  
K34	   Patients	  receive	  better	  care	  for	  chronic	  medical	  conditions	  if	  they	  have	  a	  
designated	  primary	  care	  provider.	  
	  












L.	  COMMUNITY	  INVOLVEMENT	  (ENGAGEMENT)	  
	   	   Y/N	  
L1	   Health	  facility	  has	  formal	  linkages	  to	  community	  –	  regular	  meetings	  with	  community	  on	  NCDS	   	  
L2	   Health	  facility	  communicates	  with	  community	  about	  disease	  states	  through	  media,	  gatherings,	  IEC,	  
and/or	  village	  health	  teams	  	  
	  
	  
L3	   Health	  facility	  participates	  in	  partnerships	  with	  community	  organizations	  that	  focus	  on	  NCDs	   	  









M.	  ASSOCIATIONS/PATIENT	  GROUPS	  
UGANDA	  DIABETIC	  ASSOCIATION	  
M1	   Do	  you	  have	  a	  branch	  of	  UDA	  in	  your	  facility?	  (Y/N)	   	  
M2	   Is	  the	  branch	  functional?19	   	  




M4	   What	  do	  you	  need	  from	  UDA	  head	  office?	   	  
	  
M5	   If	  no,	  are	  you	  willing	  to	  open	  a	  UDA	  branch	  at	  your	  facility?	  (Y/N)	   	  







	   Association/Group	   Contact	  information	  
M7	   	   	  
	  
M8	   	   	  
	  
M9	   	  
	  
	  
                                                
19 e.g.	  Regular	  meetings	  held,	  minutes	  available,	  work	  plans	  available,	  reports	  available	  and/or	  submitted	  to	  UDA	  









Appendix C. World Health Organization Essential Tools and Medicines for 
Noncommunicable Diseases 
 
The following tables are adapted from the World Health Organization’s Package of 
Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in 
Low-Resource Settings. 
 
Table 1. WHO essential technologies and tools for implementing essential NCD 





Blood pressure measurement device 
Measurement tape 
Weighing machine 
Peak flow meter 
Spacers for inhalers 
Glucometer 
Blood glucose test strips 
Urine protein test strips 
Urine ketones test strips 
 
Add when resources permit: 
Nebulizer 
Pulse oximeter 
Blood cholesterol assay 
Lipid profile 
Serum creatinine assay 
Troponin test strips 
Urine microalbuminuria test strips 
Tuning fork 
Electrocardiograph (if training to read and 
interpret electrocardiograms is available) 
Defibrillator 
Tools: 
WHO/ISH risk prediction charts 
Evidence based clinical protocols 
Flow charts with referral criteria 
Patient clinical record 




Table 2. WHO core list of medicines required for implementing essential NCD 




Calcium channel blocker (amlodipine) 
Beta-blocker (atenolol) 




























Glucose injectable solution 
Sodium chloride infusion 
Oxygen 
 
 
